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INTRODUCTION
It is well established that immaturity of the lung is the primary
etiologic factor predisposing to the development of the respiratory
distress syndrome of the newborn, the major cause of death i~ premature
infants.

The overall maturity of the fetal lung has been found to de-

pend to a great extent on the maturity of the type I I epithelial cells
of the alveolus.

These cells are the recognized source of lung sur-

factant, a surface tension lowering substance, rich in dipalmitoylphospatidylcholine, which lines the alveolar space and prevents the
collapse of the lung at expiration.

The type II cells contain charac-

teristic lamellar inclusion bodies, the intracellular storage form of
surfactant, as well as other secretory elements including rough endoplasmic reticulum, Golgi. apparatus and multivesicular bodies, the presumed precursors of lamellar inclusion bodies.
I

Previous studies have indicated that glucocorticoids, ard perhaps
'

other pharmacologic agents, promote fetal lung maturation by accelerating the structural, functional and biochemical development of the
alveolar· type I I cells.

Pilocarpine, a parasympathomimetic alkaloid,

has been shown by previous studies to stimulate the secretion of surfactant by type II cells in the adult.

There is little information

available concerning the effects of pilocarpine on the surfactant system of fetal animals.

There is, however, some evidence that it is

capable of causing increased secretion of surfactant in ·the later
1

2
stages of gestation.
This study was designed to investigate the reactions of the developing fetal rabbit lung to multiple maternal doses of pilocarpine
on successive days at a point in gestation when the surfactant system
is just beginning to mature.

These reactions include morphologically

demonstrable changes in surfactant synthesis and secretion as well as
changes in the maturation process of the fetal lung, such as changes
in cell numbers or cell division.
Ultrastructural studies constituted the main emphasis of this
project and employed morphometric and stereologic analyses.

These

data are correlated with light microscopic morphometric analysis,
a biochemical study and a new application of the rapid technique
of scintillation autoradiography.

,

LITERATURE REVIEW
General Concepts of the Pulmonary Surfactant System
A Swiss physician, Von Neergard (' 29), was the first t,o suggest
that the surface tension of fluid in the alveoli of the lung might be
lower than that of other body fluids, and that this might be due to the
accumulation of surface active material.

Studying pressure-volume re-

lationships in excised degassed pig and dog lungs filled with either
fluid or air, he found that the transpulmonary pressures were lower for
a given volume of fluid than air and concluded that 2/3 to 3/4 of the
retractive pressure of the lung was due to surface forces.

The theo-

retical significance of surface forces in the initial expansion of the
lungs at birth was appreciated by Hilson and Farber ( '33) and Gruenwald
('47).

Surface properties of the lung were discussed by Radford et al.

('54) in relation to the maintenance of alveolar stability

an~

the de-

l
!

termination of respiratory surface area.

A major contribution was made by Pattle ('55) who demonstrated
that bubbles expressed from the lungs were very stable in air and had
a high resistance to anti-foam agents.
had a very low surface tension,

~ess

He concluded that these bubbles

than 0.06 dynes/em.

Furthermore,

low surface tension was found to be a unique property of these pulmonary bubbles since bubbles made of fluid from other sources, such as
blood, showed no such stability and decreased rapidly in size when ex3
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posed to air.

Further studies supported his original conclusions that

the surface tension of the lining film of the lungs was very close to
zero ;(Pattle, '60, '65).

In addition, he theorized that in the absence

of extremely low surface tension, the alveolar "bubble of air" would
collapse upon itself due to the law of Laplace (P= 2y /r, whe're P=internal pressure, y=surface tension and r=the radius of the alveolus) giving rise to massive atelectasis.
Clements et al. ('57, '58) measured the surface tension lowering
properties of lung extracts obtained by rinsing lungs with 0.09% saline, mincing whole lungs in saline and squeezing material from the
cut surfaces of lungs into saline.

They found that, in vitro, as a

film of this lung material was compressed, the surface tension dropped
and, furthermore, that the changes in surface tension during compressian and expansion of the film did not coincide.

About the same time

Mead et al. ('57) described static pressure-volume characteristics of
!

saline and air filled dog lungs.

They found that in excised Jungs the
\
\

surface forces were minimized by saline filling and consequently hysteresis, or the difference between the curves on inflation and deflation, was small.

\

In air-filled lungs, however, hysteresis was marked

and much like that observed by Clements and co-workers in films of lung
extracts.
It is now well established that the major function of pulmonary
surfactant is the maintenance of alveolar stability.

As the radius of

the alveolus decreases, pulmonary surfactant reduces the surface tensian at the air-liquid interface.

If pulmonary surfactant were not

5

present, upon expiration there would be massive alveolar collapse, or
atelectasis.

Due to the action of surfactant in lowering the surface

tension, a residual volume of air always remains in the lung (Avery and
Said, '65).
Other demonstrated or theorized physiologic functions of surfactant, as reviewed by many authors including Avery and Mead ('59),
Scarpelli ( '68) , Morgan (' 71) and Read ( '71) , may be summarized as
follows.

Alveolar liquid balance.

It is thought that in the

~bsence

of surfactant the increased surface tension in the alveoli would augment capillary hydrostatic pressure and result in transudation of fluid
into the alveoli.

This may occur in some pathologic conditions of the

lung, resulting in massive pulmonary edema.

Pulmonary capillary flow.

The surface tension in the alveoli does rise during inflation of the
lung, as shown in a typical hysteresis loop.

This controlled rise in

surface tension exerts a limited amount of force which does augment
!I
capillary pressure, as described above. This regulated force: aids in
I

overcoming gravity and "pulling" blood up to the apices of the lungs.
Clearance of the alveolar space.

Although this task is accomplished

primarily by the alveolar macrophages, pulmonary surfactant does appear
to play a role.

Surfactant is cleared from the alveolar spaces, in

part, by a central flow through tbe bronchiolar tree and trachea to the
pharynx, along with the mucous sleeve of the airways.

In so doing,

debris which was trapped in the surfactant layer is carried along and
thus cleared from the alveolar space.

Reaction to infection.

The al-

veolar surface layer has also been implicated as part of the body's de-

6

fense mechanism.

This is thought to involve an antigen-antibody reac-

tion which localizes bacteria at the alveolar surface (Shifrine and
Gom:;lay, '65).
The presence of a fluid lining layer in the alveoli of mammalian
lungs was first described morphologically by Terry ('26) and subsequently elaborated upon by him (Terry, '45).

The significance of this

lining layer was, for the most part, overlooked until the 1950's when
the physiology of the surfactant system was being described.

}1acklin

('54, '55) provided the first strong morphologic evidence of an extracellular lining layer in the alveoli.

He observed that the alveoli

were lined by an "exterior alveolar mucoid fluid" which had the staining characteristics of mucopolysaccharides.

By phase contrast micro-

scopy, he observed "myelin figures" forming the layer, which he postulated as consisting of either lecithin or cholesterol.

His studies

were followed by several reports dealing with the staining af.finities

I
'

of the lining layer, all using light microscopy (Groniowsky apd
I

Biczyskowa, '69; Bernstein et al., '69; Kikkawa et al. , '70).
Convincing electron microscopic demonstration of this alyeolar
lining layer was for a time lacking, due to the difficulty in preserving it during fixation.

Weibel and Gil ('68) were the first to clearly

show the ultrastructure of this layer.

Their observations were con-

firmed by Kikkawa ('70), Kuhn ('72) and others.

It is now well esta-

blished that the alveolar lining layer consists of two portions, the
first being a mucinous coat which is an integral part of the alveolar
epithelial cell membranes (Balis et al., '71).

This is similar to
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other such coats 'vhich exist on the surfaces of many cells and is distinct from the second part of the alveolar lining layer, the surfactant
layer.

This surfactant layer, in turn, consists of two portions, a

base layer, or hypophase, which contains proteins and mucopolysaccharides and a 4 nm thick superficial lamellar layer.

This lamellar

layer is thought to be a monolayer of highly polar lipids which forms
naturally, since it is a physical property of the lipids which comprise
it to form monolayers in water (Luzzati and Husson, '62).

Weibel's

electron microscopic description agreed well with what was postulated
as the physical composition of the surfactant layer by earlier authors
(Pattle and Thomas, '61; Klaus et al., '61; Clements, '67) based on
biochemical data.
The hypophase of the surfactant layer appears, for the most part,
homogenous due to protein and mucopolysaccharide components.

However,

there are also surfactant lipids present in the hypophase which appear
I

I

as characteristic "myelin figures" or lattice-like tubular myelin, due
I

I

to the same physical forces which cause them to form monolayers (Klaus
et al., '62; Balis and Conen, '64).

·These lipids are 80% phospholipids

(King, '74) of which the major proportion is phosphatidylcholine and
phosphatidylglycerol, with some phophatidylethanolamine and sphingomyelin (King and Clements, '72; Hallman and Gluck, '75; Van Golde,
'76).

The molecular species of phosphatidylcholine are also quite

distinct, being mostly disaturated molecules and, in fact, predominantly dipalmitoylphosphatidylcholine (DPC) which comprises about 50% of
the total surfactant lipids (Toshima and Akino, '72; Van Golde, '76).
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DPC owes its great surface activity largely to its bipolar molecular
configuration - a hydrophilic choline group and two hydrophobic saturated fatty acid side chains.

This bipolar configuration causes it to

form packed layers, and the presence of saturated side chains, as opposed to unsaturated, allows the molecules to be very tightly packed
(Read, '71; Balis and Shelley, '72).

Radioisotope studies have indi-

cated that the major pathway for the de novo synthesis of surfactant
phosphatidylcholine is the CDP-choline pathway (Van Golde, '76).
Some of the confusion concerning the surfactant layer of the
alveolus was due to a long standing controversy as to whether the
alveolar epithelium was a continuous epithelium, covering the capillary
endothelial cells, or discontinuous, leaving the capillary cells exposed directly to the air in the alveolus.

In the early 1950's Low

and co-workers published electron microscopic studies of mammalian
lungs, which convincingly demonstrated for the first time tha,t the epi1
;

thelium of the alveolus was indeed continuous (Lmv and Daniels,
'52;
I
Low, '53, '54; Low and Sampaio, '57).

This work was substantiated by

the similar findings of Karrer ('56) and Kisch ('60).

It is now uni-

versally accepted that the alveoli of the mammalian lung are lined by a
continuous layer of endodermally derived cells.

The epithelial cells

cru1 be characterized as two distinct types with particular, specialized
functions.

The type I cells cover the great majority of the alveolar

surface and are essential for gaseous exchange in the lung.

They are

characterized by a central nucleus and wide, attenuated cell extensions
which form the epithelial constituent of the three layered blood-air
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barrier, the other two portions being a fused basal lamina and the pulmonary capillary endothelium.

The attenuated cytoplasm is approxi-

mately 0.1 to 0.2 ]Jm thick and thus may only be visualized using electron microscopy.

The nuclear region is approximately 0.7 ]Jill thick and

here are found the majority of the cellular organelles whichinclude
mitochondria, Golgi complex and rough endoplasmic reticulum.

The at-

tenuated cytoplasm contains few organelles but numerous pinocytotic vesicles which play a role in transepithelial transport.

Contacts between

type I cells, or between type I and type II cells, are typical "tight"
junctions with close apposition of cell membranes.

Synonyms for the

type I alveolar epithelial cell include type-B cell, small alveolar
cell, surface epithelial cell and membranous pneumocyte (Kilburn, '74).
Interspersed among the type I cells are type II alveolar epithelial cells which have also been called type-A cells, corner cells,
vacuolated and non-vacuolated alveolar cells, septal cells

~d

granular

!

pneumocytes (Kilburn, '74).

The morphometric relationships

OF

alveolar

I

epithelial cells have been documented by Weibel ('76).

In the lung of

the adult rat he found the type II cells to cover far less surface area
along the alveolar lumen than type I cells (69 ].1m2/cells vs. 4003 ].1m2/
cells).

He also observed that type II cells are smaller than type I

cells (336 ].1m2/cell vs. 812 ].1m2 /cell) but more numerous (14.1% vs.
8.3% of lung parenchymal cells).
The type II cells were first noted by Reinhardt in 1847 and so
were resolvable by light microscopy.

In paraffin sections they are

easily confused, however, with alveolar macrophages, but are readily
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studied in 1 to 2

Jllll

plastic sections.

They may be "tucked" away in a

niche in the alveolar wall, or bulging out into the lumen, being expose¢ to air on the lateral surfaces of the cell.

They may occur alone

or in groups of two or three and tend to occur more often at points
where several adjacent alveoli meet.
The ultrastructure of the type II alveolar epithelial cells has
been described by many authors including Macklin ('54), Karrer ('56),
Balis and Conen ('64), Sorokin ('67), Kikkawa ('70) and others.

The

cells rest on a continuous basal lamina, have a diameter of from 7 to
14 jlm, a spherical vesicular nucleus, which is frequently eccentric,
and a nucleolus which is usually visible.

They are roughly cuboidal

but do exhibit a great amount of pleomorphism.

The cells also exhibit

some degree of polarity in that the apical surface is covered with
short stubby microvilli which have fine axial filaments similar to
those found in microvilli on the cells of other organs (Kuhn, '68).
1

!

Mitochondria are fairly numerous within the cytoplasm and are: seen as
!

"plump" or sometimes "rod-like" struc;:tures with parallel cristae.
These cristae often fail to reach the center of the mitochondrion and
\

are less numerous than those in mitochondria of other cell types, such
as striated muscle (Sorokin, '67).

Peroxisomes have been identified

in type II cells of some species ·and are seen as enlarged bodies with a
single limiting membrane (Schneeberger, '72).

Lysosomes have also been

observed by most authors and contain acid phosphatase and other hydrolases.

There are usually two centrioles located apically in the cell,

although they are seldom both seen in 'the same ultrathin section.

One

of these may, during cytodifferentiation, send out a short cilium into
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the alveolar space; however, this never persists into the mature
stage of the cell.
The secretory nature of the cell is suggested by an abundant
rough endoplasmic reticulum which is found throughout the cytoplasm
of the cell, taking up much space between other organelles.

The

cisternae are loosely packed, differing in this respect from those
of other secretory cells, such as pancreatic acinar cells.
authors have described a flocculent precipitate within the
particularly when they are dilated (Sorokin, '67).

Some
ci~ternae,

Ribosomes are

abundant on the cisternae as well as free within the cytoplasm,
forming arrays.

The Golgi apparatus appears in section to consist

of both vesicles and stacks of lamellae in paranuclear, often apical,
locations.

In some cases there appear to be multiple vesicles of

Golgi apparatus scattered widely throughout the cytoplasm.

Multi-

vesicular bodies, although known to exist in other cells, such as

I

the ovum (Sotello and Porter, '59), are particularly prominerit in
I

I

type II pneumocytes.

These membrane bound structures may contain a

few, or many, smooth surfaced vesicles and have been observed to
incorporate Golgi vesicles (Sorokin, '67).
The most unique structure to be found within the type II cell
is what are now termed lamellar inclusion bodies.

These are, or have

been, also known as cytosomes, multilamellar bodies or alveolar
inclusion bodies.

Macklin ('54), using light microscopy, observed

osmiophilic granules in the cuboidal alveolar epithelial cells and
thus originated the term granular pneumocyte in reference to these
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cells.

In paraffin embedded tissue sections processed routinely these

granules appear as empty holes or vacuoles.

When lung tissue is pro-

cess,ed with minimal use of organic solvents, however, their contents
stain intensely with osmium, periodic acid-Schiff, sudan black and
toluidine blue.
treatment.

They are completely extracted by

chloroform~methanol

These and other histochemical reactions lead to the

conclusion that the inclusion bodies contain lipids.

By electron

microscopy, lamellar inclusion bodies appear as roughly spherical or
elongate, membrane bound and varying greatly in size.

They consist

of intensely osmiophilic lamellae, or membranes, which may be concentrically arranged or present in parallel arrays.

Some problems were

encountered in the study of the ultrastructure of the lamellar inclusion
bodies in past years due to the partial or total extraction of their
lipid content by polar dehydrants.

Because of this Scarpelli ('68)

suggested the adjective "lamellar" be omitted from their descriptive
I

title since the morphology of these inclusion bodies was undetermined
I

and variable from one report to the next.

Studies utilizing the

freeze-fracture technique (Lauweryns,and Gombeer-Desmecht, '72; Smith
et al., '72) established that the lamellar inclusion bodies were indeed
packed with lipid membranes.
remains controversial.

The periodicity of the membranes, however,

Some (Pattle et al., '72; Lauweryns and Gombeer-

Desmecht, '72) have reported a 40 nm periodicity, while others (Smith
et al., '72) felt a periodicity of 80 nm to be more accurate.

Recently,

the use of special lipid retention procedures, such as tannic acid fixation, has added considerably to the knowledge of the ultrastructure of
the lamellar inclusion bodies.

Stratton ('76), using these techniques
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and high voltage electron microscopy, found a periodicity of 66 nm to
be the most probable in vivo.
In interpreting ultrastructural observations of the lamellar
inclusion bodies, the problem of interspecies variation must be
considered.

The studies which have dealt with the periodicity of the

lamellar membranes have employed primarily rat lung, where the lamellae
are highly regular and densely packed.

Kikkawa and Spitzer ('69) demon-

strated that a great deal of variation exists in the morphology of
lamellar inclusion bodies among mammals.

For example, the inclusion

bodies of adult rabbits are somewhat vacuolated with far fewer membranes
than those of the rat, while guinea pig inclusion bodies are intermediate in terms of lamellar appearance.
Some investigators have claimed that the type II cell is merely
a phagocytic cell (Niden, '67).

Others (Shulz, '59; Klaus et al., '62)

suggested that the lamellar inclusion bodies are transformed kitochondria.

I

However, it is now well established that the type II cells

are the source of pulmonary surfactant and that the lamellar inclusion
bodies are the intracellular storage form of surfactant.

Usin~

a

method developed in 1938 (Sjostrand and Sjostrand), Macklin ('54) was
the first to suggest that the "mucoid" film of' the alveolar space was
secreted by the granular pneumocytes.

Ten years later Balis and Conen

('64) and Bensch ('64) reported a secretory function for the type II
cells, based on the electron microscopic observation of lamellar
inclusion bodies being secreted into the alveolar space.

Similar obser-

vations have since been made by many investigators in the field (O'Hare
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and Sheridan, '70; Smith et al., '79).

Some have also claimed that

this appearance might just as easily represent phagocytosis of surfactant material by type II cells.

Detailed ultrastructural studies

of the type II cell surface, however, have yielded evidence that the
lamellar bodies are indeed being secreted from, not ingested by, the
type II cell (Askin and Kuhn, '71).

Moreover, it is thought that

normal type II cells possess no phagocytic properties (Karrer, '60).
Buckingham and Avery ('62) correlated the appearance of lamellar
bodies in the fetal mouse with the first appearance of normal surface
tension properties.

This temporal relationship between the appearance

of surface activity, the alveolar lining layer and lamellar inclusion
bodies adds support to the concept of the lamellar bodies as intracellular surfactant and has since been described in the rat (Buckingham
et al., '64), rabbit (Kikkawa et al., '68), lamb (Kikkawa et al., '65)
and human (Campiche et al., '63).

Histochemical studies at the
ultrat
I
I

structural level have also indicated that the lamellar inclusion bodies
consist of phospholipids very similar in all respects to those found in
the surfactant layer of the alveolus (Campiche, '60; Sorokin, '66;
'

Dermer, '70), thereby linking the two.
More recently, strong

~vidence

in support of the relationship

between lamellar inclusion bodies and surfactant synthesis has come
from studies employing radiolabelled surfactant precursors.
Kuhn ('71) administered

Askin and

3
H-palmitate intravenously to rats and found

that it was incorporated primarily into the surfactant lipid lecithin.
At all time periods studied they found heavy labelling of type II
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alveolar cells and specifically the lamellar inclusion bodies.
Chevalier and Collet ('72) studied the incorporation of several precurso~s

into lung epithelial cells, using electron microscopic auto-

radiography.

They observed that

3

H-choline, a specific precursor of

surfactant phosphatidylcholine, selectively labelled type II pneumocytes.
In addition, they provided evidence that the lamellar inclusion bodies
are formed through a process similar to that found in other secretory
cells.

After initial incorporation in the rough endoplasmic reticulum,

the labelling was found progressively over the Golgi apparatus, the
lamellar bodies, and then finally in the alveolar space over the
myelin figures, which are thought to represent secreted surfactant.
These findings have been substantiated by Massaro and Massaro ('72)
in an autoradiographic study of intracellular surfactant protein transfer
in type II cells.

Although autoradiographic evidence has appeared which

favors the view of the Clara cell of the terminal bronchiole as the

I

source of surfactant (Niden, '67; Etherton et al., '73), other reports.
I

have convincingly demonstrated that the secretion of the Clar1a cells is,
in major part, proteinaceous in
'76).

natu~e

(Roth and Meyer, '72; Ebert et al.,

In addition, comparative autoradiographic studies have ?lso

added support to the concept of the type II cell as the source of
surfactant (Adamson and Bowden, '73; Frasca, '77).
Since the lung consists of over 40 individual cell types (Sorokin,
'70), detailed biochemical or functional studies of type II cells alone
have been lacking.

Recently, however, some investigators have been

able to isolate relatively pure populations of viable type II cells.
~ikkawa

and Yoneda ('74) were the first to accomplish this in rat lung,
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and with co-workers ('75) published a valuable study of the composition and synthetic activity of type II cells.

Others (Fisher and

Furip, '77; Mason et al., '77; Pfleger, '77) have since accomplished
similar isolations and have contributed information concerning the
role of the type II alveolar epithelial cell in surfactant synthesis,
storage and release.
Through the various lines of evidence discussed above, and
innumerable studies, the following scheme of lamellar body synthesis
and surfactant secretion has been well established.

The lipids and

proteins are synthesized in the rough endoplasmic reticulum and passed
on to the Golgi apparatus, where vesicles are "pinched" off and
packaged as multivesicular bodies.

These then undergo a lamellar

transformation to mature inclusion bodies while approaching the apex
of the cell.

Upon reaching the apex the limiting membrane of the

lamellar body fuses with the cell membrane, and the membranous contents
I

of the inclusion body are discharged into the hypophase of

th~

existing

I

alveolar lining layer.

In the alveolar space the molecules of sur-

factant may take part in forming the 4 nm thick surface active film,
or remain in reserve in the hypophase, forming myelin figures or
tubular myelin arrays.

The process of the lamellar body membranes

unfolding and rearranging to form tubular myelin arrays in the hypophase has recently been convincingly demonstrated by the use of high
voltage electron microscopy (Williams, '77; Sanderson and Vatter, '77).
To complete the story, "used" surfactant is thought to leave the
alveolar space in several ways.

It may flow up the respiratory tree,

be phagocytized by the alveolar macrophages present in the hypophase,
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be absorbed through the alveolar epithelium or enzymatically degraded in situ (Goerke, '74).
Fetal Lung Development
The lungs of all mammals, including man, which have been studied
during the course of their development have been found to share a common pattern of origin, development and maturation.

The epithelium of

the respiratory tract originates as a diverticulum from the endoderm
of the caudal pharynx (Moore, '73; YokohJ '77).

This diverticulum

elongates as the laryngotracheal tube, developing lung buds which
grow and divide by dichotomous branching to form primitive respiratory passages.

The mesenchyme surrounding the endodermal outgrowth

is destined to become the smooth muscle, cartilage and blood vessels
of the lung.

It has been shown that specific interaction between the

endoderm and mesoderm is essential for normal lung growth and cellular
differentiation (Taderara, '67; Masters, '76).
Further development of the lung may be divided into three major
periods.

The glandular (pseudogland~lar) period is the earliest and

is so called because the microscopic appearance of the lung at this
stage resembles glandular tissue.

The air conducting system develops

during this period and the potential airways are lined by a low
columnar to high cuboidal epithelium.

Also during this period, the

mesenchymal mass around the airways is condensing.

The canalicular

period is characterized by enlarging respiratory passages which are
lined by cuboidal epithelium, by a vascularization of the surrounding
mesenchyme and by the appearance of primitive respiratory bronchioles
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and what may be termed alveolar septa (Conen and Balis, '69).

The

/

alveolar period is the final stage of development and is characterized.by the massive proliferation of alveoli and the thinning of the
the alveolar septa.

Concurrent with this is the development of the

great majority of the blood-air barriers which will be requi'red for
gaseous exchange.

Since only 1/8 to 1/6 of the adult number of

alveoli are present in the lungs at birth, in the human this stage is
said to continue up till the age of ten years (Moore, '73).
Although it was generally accepted that the epithelium of the
air conducting system was an endodermal derivative, the germ layer
origin of the alveolar epithelium was, for a time, in question.
Policard et al. ('57) felt that both the type I and type II alveolar
epithelial cells were of mesodermal origin.

Many investigators,

influenced by its reported phagocytic characteristics, believed that
the type II cell was of mesodermal origin, as is the

alveola~

macro-

t

phage (Divertie and Brown, '64; Bertalanffy, '64).

Others (Lpw and
I

Sampaio, '57; Campiche et al., '63; Suzuki, '66) thought that a common
endodermal origin was more likely, judging by the junctional complexes
'

between type I and type II cells and the presence of a common basal
lamina.

Morphologic (Kikkawa et al., '68; O'Hare and Sheridan, '70)

and autoradiographic (Hitchcock, ·'68) studies have established the
concept of a common endodermal derivation for all the respiratory
passages, including both types of alveolar epithelial cells.
The mature type I and type II epithelial cells which are found
in the alveolus of the term fetus both stem from a common immature
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cuboidal cell which is already present at the canalicular phase of
development.

The internal organization of this undifferentiated cell

is relatively simple, in that a great deal of the cytoplasm is filled
with fairly densely packed glycogen and varying, usually small, amounts
of rough endoplasmic reticulum.

A few mitochondria are also present,

but inconspicuous, and the Golgi is normally lacking.

Lamellar inclu-

sian bodies or multivesicular bodies are not present.

If a given

immature cuboidal cell is destined to become a type I cell, extensions
begin to grow out from its lateral borders while a gradual thinning
of the entire cell takes place (Balis et al., '66; Adamson and Bowden,
'75).

The internal organization of the cell remains at about the

same simple level of the undifferentiated cell, although occasionally
a poorly formed lamellar inclusion may be observed (Mercurio and
Rhodin, '76).

This, however, is occasionally true of type I cells in

the adult lung as well (Kikkawa and Kaibara, '72).

The major intra-

cytoplasmic change which occurs during the differentiation

o~

type I

!

cells is the loss of glycogen as the extensions thin to form blood-air
barriers.

As these blood-air

barrie~s

mature, they become thinner

by the attenuation of the type I epithelium and, often, by the,repositioning of the capillary cell nucleus.

At earlier stages these nuclei

lie directly under the epithelial component of the blood-air barrier
but, as maturation proceeds, they come to lie at the opposite pole of
the capillary, toward the alveolar septa.
The same immature cuboidal cells may also undergo major changes
during the differentiation to mature type II cells.

These changes all

correspond with the cell developing the cytoplasmic specializations

20

required for the manufacture and secretion of pulmonary surfactant.
A cuboidal cell which lines the fetal alveolus may be termed a type II
cell~

as such, at the first appearance of lamellar inclusion bodies.

This occurs rather late in gestation and, as mentioned, is one
criterion which helped link the lamellar inclusion bodies to the
synthesis of surfactant.

Of course the secretory apparatus which

manufactures the surfactant is also becoming highly developed during
this same time.
One of the hallmarks of the differentiation of type II cells
from their immature cuboidal precursors is the loss of the glycogen
content which had been built up by the immature form (Brandstrup and
Kretchmer, '65; Kikkawa, '68).

It is thought that this decrease in

glycogen content occurs because of the increase in surfactant synthesis.

Glucose has been shown to be an important precursor for phos-

phatidylcholine synthesis in the adult rabbit lung (Felts,

'~4),

and

there is indirect evidence that glycogen is a precursor for, :or is
!

somehow necessary for, phosphatidylcholine synthesis in fetal rabbit
lung (Gilden et al., '77).

Finally, as the cell matures there occurs
I

an increase in the number of lamellar inclusion bodies and their
precursor forms, multivesicular bodies.
This basic scheme of differentiation and maturation in the
alveolar epithelium has been studied in many mammals including the
human (Balis and Conen, '64; Campiche, '63; McDougall and Smith, '75),
lamb (Kikkawa et al., '65), rat (O'Hare and Sheridan, '70; Hilliams,
'77), mouse (Woodside and Dalton, '58), pig (Baskerville, '76) and
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hamster (Banks and Epling, '71).

Kikkawa and co-workers ('68, '71)

and Motoyama et al. ('71), working with Kikkawa, have contributed
greatly to the understanding of the morphologic development of the
alveolar epithelium in the rabbit.
as follows:

Their findings may be summarized

On the 21st gestational day a columnar epithelium contain-

ing a moderate amount of glycogen lined the respiratory passages.
These cells also contained quite a few profiles of rough endoplasmic
reticulum which, in some cases, were distended.
was often present, but inconspicuous.

The Golgi apparatus

The alveolar epithelium of the

24th gestational day was characterized by the presence of large amounts
of glycogen packed densely into the cells.

The cells also contained

a few mitochondria and rough endoplasmic reticulum similar to that
observed at the 21st gestational day.

Various oval shaped, electron

dense bodies were found in the vicinity of a well defined Golgi.

In

26 day fetal rabbit lungs they observed some differentiation lof the
alveolar epithelium into type I and type II cells.

The type :I cells
I

at this point contained no glycogen ?nd were already fairly well
attenuated.

The type II cells contained large amounts of glycogen,

some lamellar inclusion bodies and an occasional multivesicular body.
Fetal lung examined at 27 days showed type I and type II cells which
were fairly well differentiated, ·and a further decrease in the glycogen content of the type II cells.

At 28 days of gestation Kikkawa

concluded that the fetal rabbit lung, including the type II epithelial
cells, was completely mature.

He based this primarily on the lack

of glycogen, the presence of blood-air barriers and the observation
of relatively numerous lamellar inclusion bodies.
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Kikkawa has also described a maturation process for the lamellar
inclusion bodies within the fetal rabbit type II cells ('69).
imm~ture

The most

of the inclusion bodies are uniformly electron dense with

perhaps one or two lamellae within them and were termed "dense bodies"
by Kikkawa.

"Transitional forms" were the next stage of the matura-

tion process and were characterized as possessing a number of well
formed lamellae with varying amounts of amorphous, electron dense
material in the center.

Finally, "fetal inclusions" were the most

mature forms described by Kikkawa and consisted of many well formed
lamellae.

The mature lamellar inclusion body of the fetal rabbit lung

possesses many more lamellae than that of an adult rabbit, although
the reason for this difference has not become clear.

Recently, this

high degree of lamellar development in fetal rabbit inclusion bodies
has been confirmed by the application of freeze-fracture techniques
(Kikkawa and Manabe, '78).

I
I
Any study dealing with the maturation of the fetal lung: has had
I
I

to take into account the fact that different portions of the lung
mature at different rates.

Howatt et al. ('65) observed that the
\

upper lobes of premature newborn lambs were more compliant and that
surfactant appeared earlier here than in the lower lobes.

Kikkawa

et al. ('71), using morphologic c!riteria, reported that the apex of
the right upper lobe of the fetal rabbit lung was advanced 1.5 gestationa! days beyond the maturational stage of the base of either lower
lobe.
Cellular proliferation in the fetal lung is .also of interest in
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describing maturational changes occuring prenatally.

Sorokin ('61)

demonstrated that the mitotic index of lung parenchymal cells decreased with advancing gestational age.

In an extensive autoradio-

graphic study of cell proliferation in fetal rat lung, O'Hare and
Townes ('70) reported that the labelled cell indices of alveolar
epithelial cells and lung interstitial cells was constant in the midportion of gestation, but abruptly decreased in late gestation.

They

administered tritiated thymidine to pregnant rats and, in others, injected colchicine in order to study mitotic indices.

The results of

the two studies showed comparable trends and thus provide evidence
that the

3
H-thymidine indices are accurate reflections of mitotic

activity in fetal lung cells.

They also concluded that the decreas-

ing mitotic and labelling indices paralleled the reduction of glycogen
levels in pulmonary epithelial cells.

Essentially the same results

were reported by Kauffman ('75) in a similar autoradiographic study
of cell proliferation in fetal mouse lung.

She concluded

I

th~t

the

'

decrease in cell proliferation in late gestation was due to the fact
that the cells undergoing differentiation were removed from the proliferative "pool" of earlier gestational ages due to a significant
increase in cell cycle time.
Scintillation Autoradiography
Although the foregoing studies utilized autoradiography, they
illustrate a drawback which is common to all autoradiographic studies,
the length of time necessary to obtain adequate exposure of the emu!sion.

The technique of scintillation autoradiography was pioneered by
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Panayi and Neill ('72) based on a somewhat similar technique which had
been previously described for use in paper chromatography (Wilson,

('58) and thin layer chromatography (Luthi and Waser, '65).

By dip-

ping emulsion coated slides in a scintillation mixture, Panayi and
Neill were able to reduce the exposure time to one day in a'study of
cell division in lymphocyte cultures.

Durie and Salmon ('75) also

studied blood cell division using this technique and were able to
shorten the exposure time to six hours by the use of tritium with a
high specific activity.

Platkowska ('76) employed stripping film

autoradiography and a scintillation mixture in a study which employed
6

~m

paraffin tissue sections as well as lymphocyte smears.

This

technique has also been applied to the study of chromosomal DNA synthesis in the lily plant (Sen et al., '77) and drosophila (Mukherjee
and Chatterjee, '77).

In the only study to date using plastic embed-

ding, Fischer et al. ('71) used a related technique of mixing scintillator with Epon resin and obtained electron microscopic aJtoradiographic results after 14 days of exposure.
Respiratory Distress Syndrome of the Newborn
Interest in the type II epithelium, its maturation and the
secretion of surfactant in the fetus was stimulated by the observation of Avery and Mead ('59) that the lungs of infants who had died of
respiratory distress syndrome of the newborn (RDS) lacked sufficient
amounts of pulmonary surfactant.

RDS afflicts approximately 1,000

premature infants per week in the United States alone (Gluck, '73)
and although therapeutic measures designed to .date have increased the
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likelihood of survival, it remains a major disease with a high mortality rate.

Those infants who do survive often develop neurologic

and;intellectual deficits due to the significant post-natal anoxia
associated with RDS.
The clinical disease entity as such has been the subject of excellent reviews (Villee et al., '73; Farrell and Avery, '75) and
therefore only morphologic features relevant to this project will be
discussed briefly.

It has been clearly demonstrated that the lungs of

most infants who develop RDS are at an immature stage of maturation at
birth, in that the alveoli are predominantly lined by characteristically immature type II epithelial cells and possess relatively few
blood-air barriers (Balis et al.,'66).

This anatomic immaturity of

the lung may lead to a deficiency of surfactant secretion, difficulty
i.n inflating the lung at birth and consequent expiratory atelectasis.
Anoxia and other factors lead to necrosis of type I epitheliqm and
ii

increased transudation of plasma proteins.

This results in fprmation
I

of the characteristic hyaline membranes found at autopsy in the lungs
of infants who succumb to RDS.

Lungs of infants who survive follow-

ing therapeutic management show a regenerated alveolar epithelium, composed of immature type II cells, which progressively matures.
should be emphasized that the

pr~cise

It

structural, functional and bio-

chemical characteristics of the infant lung at birth, with or without
RDS, have not been well documented and many in utero factors may
influence these characteristics.
The normal infant, possessing a mature lung whose alveoli
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contain sufficient surfactant at birth, retains 50% of the air which
it inhales with its first breath (Karlberg et al., '62).

This func-

tional residual volume is the hallmark of pulmonary maturity and what
is decidedly lacking in the premature infant with insufficient surfactant at birth.
Drug Induced Alterations of Fetal Lung Maturation
The findings of Avery and Mead ('59) have been substantiated by
many investigators.

This established relationship between RDS, lung

surfactant and the maturity of the type II alveolar epithelium led to
investigations concerned with factors which could possibly influence
the maturation of the type II epithelial cells and the production of
surfactant in the fetus.

Buckingham et al. ('68) were the first to

propose that glucocorticoids might accelerate lung cell differentiation.

They theorized that since

glucocorticoi~s

were known

~o

have a

stimulatory effect on cell differentiation in the epithelium pf the
I

developing digestive tract (Moog and Richardson, '55) they might also
have this effect on the epithelium of the fetal alveolus since it too
is an endodermal derivative.
Liggins ('69) administered glucocorticoids to pregnant sheep
and found that when he delivered the lambs prematurely, they survived
significantly more often than control lambs delivered at the same
gestational age.

Direct injection of cortisol into rabbit fetuses

in utero has been morphologically demonstrated to accelerate the maturation of type II alveolar epithelial cells (Kikkawa et al., '71;
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Motoyama et al., '71).

This conclusion was based on an earlier

decrease in glycogen content associated with an increase in the number
of lamellar inclusion bodies present within the type II pneumocytes.
In addition, type I cells began the attenuation process sooner, resulting in the appearance of blood-air barriers at an earlier stage
of gestation than in controls.

Related findings indicating increased

maturation in the lungs of glucocorticoid-treated rabbit fetuses have
also been reported by Wang et al. ('71) and Kotas and Avery ('72).
In order to rule out the interference of other hormones which may have
been stimulated through pituitary feed-back loops, Blackburn et al.
('72) using rats and Chisweck et al. ('73) using rabbits, decapitated
fetuses in utero and studied type II cell maturation.

The results of

both studies indicated a retardation of type II cell differentiation
with decreased numbers of lamellar inclusion bodies present within the
cells.

However, in the study of Chisweck, when a synthetic analog of

I

ACTH was administered to the fetal rabbits, these changes wer.e
I
I

abolished, indicating a possible hypophyseal controlling mechkmism
for lung maturation in vivo.
'

Since the first experiments of Liggins, there has appeared a
wealth of literature documenting the acceleration of maturation of the
fetal lung following glucocorticoid treatments (for review see Farrell
and Avery, '75).

In addition, controlled clinical trials have been

implemented which have suggested that the administration of steroids
to pregnant mothers 1-2 days prior to delivery may decrease the incideuce of RDS in high risk pregnancies, but is only effective if delivery occurs before the thirty-second week of gestation (Liggins and
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Howie, '72) •
As promising as the foregoing studies appear to be, however,
glucocorticoid administration has not gained universal acceptance as
the clinical answer to RDS.

Although there have been reports of de(

creased cortisol levels in infants afflicted with RDS (Murphy, '74),
others have indicated no such decrease and, indeed, found elevated
cortisol levels in infants similarly afflicted (Reynolds, '73).

In

addition to the problem of tl\ese conflicting clinical reports, some
studies have revealed possible deleterious effects of steroid treatment of the fetus and/or newborn.

Kotas et al. ('74) and Carson

et al. ('73) have documented an inhibition of total lung cell number
after hydrocortisone therapy in fetal rabbits.

Picken et al. ('74)

found that the administration of corticosteroids, on a longer term
basis, resulted in a significant increase in the elastic recoil of the
lungs in treated animals and the appearance of "giant" lamellar bodies

I

within the type II cells.

They concluded that the long-term ladmin\

istration of glucocorticoids resulted in a decided impairment of
surfactant secretion.

In addition to these possible deleterious

effects in the lung, other, far reaching, problems have been reported
following corticosteroid administration.

Impaired cellular develop-

ment of the cerebrum and cerebellum was observed in rats treated postnatally with steroids (Cotterrell et al., '72) and neurologic deficits
including impaired motor co-ordination and balance were reported in
mice following similar treatment (Howard and Granoff, '68).

Older

reports of side effects in the glucocorticoid therapy of human infants
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also hold significance.

Treating premature infants with ACTH for

retrolental fibroplasia, Silverman et al. ('51) observed a retardation
of growth which was reversible following the cessation of treatment.
In addition, neurologic deficits were described by deLemos and
Haggerty ('69) following prednisolone therapy of infants suffering
from bacterial meningitis.

More recently, several reports have ap-

peared dealing with previously unknown side effects of the clinical
trials of steroid therapy for RDS which were attempted.

Taeusch et

al. ('73) as well as Ewerbeck and Helwig ('72) have reported extensive
intraventricular hemorrhages following steroid treatment.

In addition,

various neurologic abnormalities have also been reported as long-term
sequelae of such clinical steroid intervention for RDS (Fitzhardinge
naL, '74).

Because of the conflicting reports of the usefulness and possible deleterious side effects of corticosteroid treatment for !the prevention and/or treatment of RDS, investigations have begun in:to the
I
I

possibility of influencing fetal lung maturation through other means.
Other agents which are thought to be capable of affecting the maturation of the fetal lung are discussed in reviews by Cowan ('74)\and
Avery ('75).

The list of such agents now includes

~hyroxine

(Wu et

al., '73), aminophyllin (Karotkin et al., '76), prolactin (Hamosh and
Hamosh, '77), plasminogen (Ambrus et al., '77) and heroin (Taeusch et
al., '73).

In addition, there has been an increase in studies design-

ed to ascertain the mechanisms at work in vivo which control the
maturation of the lung and the initiation of surfactant synthesis and
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secretion in the fetus.
Autonomic Manipulation of the Surfactant System
The first indication that the parasympathetic nervous system
could be involved in the maintenance of the type II alveolar'epithelium and the secretion of surfactant came from studies of vagotomized
animals.

Early investigators in the surfactant field had noted ab-

normal alveolar surface tension (Klaus et al., '62) as well as

mor-

phologic changes in type II alveolar cells (Eolande and Klaus, '64)
in the lungs of vagotomized animals.

In addition, Miller et al. ('51)

--

observed hyaline membranes similar to those found in the lungs of
infants who had succumbed to RDS.

Goldenberg et al. ('67) performed an

in depth study of the ultrastructural changes in alveolar type II
cells of rats following bi-lateral cervical vagotomy.

They described

a severe loss of osmiophilia and membrane structure within the lamellar inclusion bodies as quickly as one hour post-vagotomy.

1

They also
!
I

I

observed a loss of multivesicular bodies and changes in the secretory
apparatus of the type II cells.

They concluded that intact vagal

connections were a necessity for normal surfactant production
secretion.

~nd

Based on these findings, they reasoned that a parasympa-

thomimetic should have a stimulatory effect on surfactant secretion.
They chose to try pilocarpine (Goldenberg et al., '69) a cholinomimetic (parasympathomimetic) alkaloid which is used by ophthalmologists to
increase the secretion of the aqueous humor in the treatment of glaucoma.

The principle action of pilocarpine is the stimulation of the

same autonomic effector cells which are acted upon by cholinergic
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post-ganglionic nerve impulses.

The compound is obtained from the

leaflets of two South American shrubs (Pilocarpus jaborandi and
Pilocarpus microphyllus) and is commercially available as pilocarpine
nitrate or, as used by Goldenberg and associates, pilocarpine hydrochloride.
The pharmacologic properties of pilocarpine mimic, for the most
part, a massive parasympathetic stimulation.

Administration of 10-15

mg in man causes marked diaphoresis, salivation, lacrimation and increased secretion of the pancreas and gastrointestinal glands. Pilocarpine also causes a generalized increase in smooth muscle tone in
most organs, including the gastrointestinal tract, respiratory tract,
biliary system and urinary system.

The only exception to its general

parasympathetic-like effects are an increase in heart rate and hypertension.

It is thought that this is due to a limited stimulation of

sympathetic ganglia (Koelle, '75).
I

Goldenberg and associates ('69) injected adult fasted rats with
a single subcutaneous dose (150 mg/kg) of pilocarpine and sacrificed
them at .5, 1, 2, 4, 7, 10, 14, 18, 21 and 24 hours after injeption.
By light microscopy they observed a dilatation of the alveoli and the
presence of apparently proteinaceous material within the bronchiolar
and alveolar lumina soon after injection.

By 24 hours post-injection

the alveoli were either collapsed or dilated.

Electron microscopy of

the type II alveolar cells at .5 hours post-injection revealed a massively dilated rough endoplasmic reticulum which contained abundant
granular material.

At one hour they noted a significant increase in
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the numbers of multivesicular bodies present within the type II cells.
Examination at two hours following pilocarpine administration revealed
larg~,

highly osmiophilic lamellar inclusion bodies within the type

II cells and an increase in the amount of intra-alveolar membranous
material.

Four hours post-injection the type II cells contained

groups of large, mature inclusion bodies which were gathered at the
apex of the cell.

These were frequently observed to be discharging

their contents into the alveolar space.

The type II cells at seven

hours contained relatively few inclusion bodies and thereafter returned to the appearance of controls.

Based on these observations,

Goldenberg and co-workers concluded that pilocarpine had a frank
stimulatory effect on the exocrine secretory mechanism of the alveolar
type II cells which was maximal at 2-4 hours after injection.
This stimulatory effect of pilocarpine was substantiated by
Petrik's report ('69) of "grill structures" in the bronchiolels of mice
I

which had received the same dosage of pilocarpine used in Golpenberg's
study.

These structures were what are now termed tubular myelin

arrays and represent surfactant.

Kirkland ('70) reported a reduction

in the surface tension of lung extracts in rats treated with pilocarpine, and concluded that this was due to an increase in the amount of
pulmonary surfactant which had been released into the alveolar space
in treated animals.

At about the same time Ivemark and Robertson

('70), in a short report of a study dealing primarily with the effects
of high vitamin A, mentioned an increased phospholipid content and
lower minimal surface tension of lung extracts in rats treated with
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pilocarpine.

Morgan and Morgan ('73)

administered 1.5 mg/kg pilo-

carpine intra-peritoneally to rats while simultaneously injecting
14 c-palmitate into the left atrium via an in-dwelling catheter.

The

phospholipids from lung washes and homogenates of these rats were
separated by thin layer chromatography and analyzed for lipid phosphorus and radioactivity.

They found that pilocarpine significantly

increased lecithin tum-over rates due to an increased secretory
activity in type II cells.

Massaro ('75), in order to study the

secretion of the protein portion of pulmonary surfactant, injected
radiolabelled leucine as well as 3 mg/kg pilocarpine to adult rabbits.
By isolating the surface active fraction from lung lavages and assaying for protein, he found that pilocarpine caused a 2.5 fold increase
in the percentage of radiolabelled surfactant protein.
The anatomical connection between the autonomic nervous system
and the alveoli of the lung was first suggested by Meyrick aid Reid
(' 71) who reported electron microscopic observations of

nerve'~

in the

I
alveolar walls of rats.

These were thought to correspond to those

previously demonstrated by light microscopy (Hirsch et al., 68).

Hung

'

et al. ('72), using electron microscopy, demonstrated an abundance
of nerves in the walls of alveolar ducts and alveoli of mice.

They

reported finding such nerves in every section of every block they examined from 18 different mouse lungs and, furthermore, reported finding two distinct types of nerve endings.

The first type had an en-

larged terminal containing many small mitochondria and was found in
the pulmonary interstitium, either alone or related to type I pneuma-
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cytes.

The second type of nerve ending was described as being packed

with large dense-core vesicles and forming an enlargement adjacent to
typ~

II pneumocytes.
The first type of nerve ending described by Hung and co-workers

resembled typical sensory endings and were theorized as being such.
The second type, although fewer in number than the first, are far more
unique, since they provide the morphologic connection between the autonomic nervous system and surfactant secretion.

This type of nerve

ending in the lung most closely resembled a type of axon found in the
pars tuberalis of the pituitary, as reported by Unsicker ('71). Hung
and colleages theorized that the substance in the dense-core vesicles
of the terminal, upon vagal stimulation, would diffuse out of the axon
and effect not only the type II pneumocyte adjacent to it, but also
others at some distance away.

The first type of ending, the sensory

portion, was also thought to be of vagal origin, making both !afferent
I

and efferent pathways vagal.

Stimulation of the left vagus

i~

rabbits

by Oyarzun and Clements ('77) resulted in a bi-lateral increase in
alveolar phospholipids, apparently due to crossing over of fibers in the
I

rabbit vagi.

Oyarzun and Clements also reported a similar effect in

rabbits subjected to substantial increases in ventilation.

This effect

could, however, be completely bldcked by atropine which led them to
conclude that, although the exact neural or humoral pathway for this
reflex increase in surfactant following increased ventilation was
unknown, it was reasonable to expect that the effect was mediated
through cholinergic mechanisms.
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In addition to pilocarpine, another parasympathomimetic,
oxotremorine, has been implicated as having a stimulatory effect on
surfactant secretion.

Abdeblatif and Hollingsworth ( '77) reported that

an intra-peritoneal injection of oxotremorine to neonatal rabbits
resulted in a significant increase in the phosphatidylcholine (PC)
content of alveolar washes.

Because they found no increase in the PC

content of the residual lung, however, they concluded that the drug
did not affect production.

This conclusion, however, may not be valid

since they sacrificed the animals thirty minutes after injection and
an effect on production of surfactant would not be expected until
perhaps two hours.
In 1976 Corbet et al. published the results of the first study
dealing with the effects of pilocarpine on the surfactant system in
the fetus.

They injected 150 mg/kg pilocarpine in 0.1 ml of saline,

or saline alone, intra-peritoneally to fetal rabbits of gestational ages
i
i

25.5, 26.5, 27.5, 28.5 and 29.5 days.

This was accomplished by anes1

thetizing the pregnant does with methoxy-flurane, performing a laparotomy and injecting the fetus through the intact uterine wall.

The

abdomen of the does was then closed, to be re-opened 2.5 hours after
injection.

Fetal lung was then obtained and pressure-volume studies

performed on intact lungs.

Corbet and associates found that, in fetal

lungs from rabbits of 25.5, 26.5 and 27.5 gestational days, this pilocarpine treatment resulted in substantial improvement of retention of
air on deflation to low pressures.

This would indicate an increase

of surface activity '"ithin the alveoli, and thus an increased secretion
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of surfactant.

They found, however, no significant differences from

controls in fetuses of 28.5 or 29.5 gestational days and interpreted
this; as indicating that the lungs were already functioning at minimal
surface tension without the pilocarpine stimulus.
In a related study Pysher et al. ('77) using explants of fetal
lung in culture observed that, at a concentration of

10-

6

M, pilocar-

pine significantly increased the release of radiolabelled lecithin
after three hours of incubation.
In order to clarify the mechanism of action of pilocarpine in
the fetal lung Corbet et al. ('77) performed another study, this time
using various autonomic agents and their antagonists.

Employing the

same operative procedure used in their earlier study, they administered saline, pilocarpine, muscarine (a parasympathomimetic similar in
action to pilocarpine), atropine (a cholinergic antagonist), isoxsuprine (as-adrenergic agonist), propranolol (a s-adrenergi~ antagonist), phenylephrine (an a-adrenergic agonist) and

I

phenoxyben~amine

(an a-adrenergic antagonist) alone or in appropriate combinations.
They found the stimulatory effect of pilocarpine on the
su~factant

olol.

secret~on

of

in the fetus to be blocked by either atropine or propran-

The stimulatory effect was mimicked by isoxsuprine, which could

not be blocked by atropine but could be by propranolol.
no stimulatory effect, nor did phenylephrine.

Muscarine had

These and the results

of other combinations, led Corbet and co-workers to conclude that the
action of pilocarpine is due to a stimulation of S-adrenergic receptors,
possibly on the surface of type II alveolar epithelial cells.

The
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nerve endings which were reported by Hung et al. ('72) would, in
Corbet's view, then be sympathetic, S-adrenergic in nature.
This theory gains some measure of support from other reports of
the action of isoxsuprine (the s-adrenergic agonist) in the fetal lung.
(

Enhorning et al. ('77) injected isoxsuprine intra-muscularly to rabbit
fetuses at the 28th gestational day and reported an increase in surface activity of the lung wash.

Hayden et al. ('77) treated rabbit

fetuses at 26.5 gestational days with three doses of isoxsuprine, eight
hours apart, sacrificed the animals 26-30 hours after the last injection and observed an increase in lung lecithin over control values.
In a clinical

sur~ey

of newborn premature infants whose mothers had

been treated with ritodine (another s-adrenergic drug) prior to delivery, Boog et al. ('75) reported a decreased incidence of RDS when
compared to fetuses of similar birth weight born to mothers receiving
no such treatment.

In another clinical case review Hastwell ,('77)
i

reported a possible therapeutic benefit

o~

salbutomol (anothe\' S-adre-

nergic agent) in preventing RDS in infants born prematurely.

'

Although the preceding studies seem to indicate that sympathetic
activation would stimulate the secretion of surfactant, there exists
some dispute in the literature.

Bergren and Beckman ('76) reported

decreased lung compliance, indicating decreased surfactant, in animals
following sympathetic stimulation.

Beckman et al. (' 71) had previously

found similar results in monkeys following head injury and reported
that this effect was due to sympathetic activation, since it could
be blocked hy sympatholytic agents.
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None of the studies to date dealing with the autonomic manipulation of the fetal lung surfactant system has described morphologic
changes following administration of autonomic drugs.

Furthermore,

all of the previous studies have involved the direct injection of the
autonomic agents to fetuses while in utero.

This procedurer'involves

surgical trauma to both the mother and fetus prior to the administration of the drug, in addition to possible effects of the anesthetic
used.

That this is not the ideal situation is pointed out by the

findings of Robert et al. ('75) which indicated that the lungs of
fetuses injected with saline in this manner showed evidence of a marked
acceleration of maturation, when compared to similar fetuses of nonoperated mothers.

MATERIALS AND METHODS
Animal Care and Mating
Large white New Zealand rabbits (average approximately 3.2 kg)
I

were procured from Langshaw Farms (Augusta, Michigan) and used for
all experiments.

All animals were housed in the same room under

identical conditions.

They were fed a standard diet of approximately

90 g of lab chow (Wayne rabbit ration) per day and were allowed water
ad libitum.

In some cases the amount of water intake by a given

rabbit was recorded daily.

The external genitalia of the females

were examined periodically in order to determine which animals would
be receptive to the males.

Females judged to be receptive were placed

in the cage of a male and held in place while mating was accomplished.
This procedure was then repeated with a second male.

Mating was always

completed within a fifteen minute period between the hours
4 PM.

The time of mating was recorded and considered to be

o~

2 and

t~me

zero

of gestation.
Experimental Protocols
Table I lists the types of experiments performed in this study
along with the numbers of litters employed in each type.
Multiple Injections (Standard Regimen) --28 days
A solution containing 20 mg pilocarpine hydrochloride (Sigma
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TABLE I
EXPERIMENTAL PROTOCOLS
Gestational Number of
Age
Litters
at Sacrifice

Pilocarpine
Dosage

Time After First
Injection
Animal Killed

5 mg/kg-4 days

4 days
7 days-

Standard Regimen
28
31

18

28
31

15
2

25
26
27
29
30

2
2
2
2
2

25
26
27

2
2
2

Control

27
28
29
30

3
4
11
2

Pilocarpine

27
28
29
30
31

2
3
17

27

1

28

1

Control
Pilocarpine

2

II

Time-Course
Control

Pilocarpine

'-

5 mg/kg-1 day
5 mg/kg-2 days
5 mg/kg-3 days

1 day
2 days
3 days

Single Injection

2
2

20 mg/kg
20-40 mg/kg
10-80 mg/kg
10,15 mg/kg
10 mg/kg

6,24 hours
3,24 hours
2,3,6,12,24 hours
24 hours
24 hours

Injection of
Fetuses in utero
Control
and
Pilocarpine

24 hours
10 mg/fetus

24 hours
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Pharmaceutical) per ml of 0.9% saline was prepared fresh for each set
of experiments.

On the 24th gestational day pregnant female rabbits

were;weighed and a dose of 5 mg pilocarpine per kg of body weight was
prepared by diluting the appropriate amount of the previously prepared
stock solution of pilocarpine to 1 ml with 0.9% saline.

This was then

placed in a 1 ml tuberculin syringe and injected subcutaneously in the
region of the upper back of the pregnant female rabbit.
injected with 1 ml of saline alone.

Controls were

These injections were repeated

daily on the 25th, 26th and 27th gestational days and are designated
for convenience as the standard regimen.
At the 28th gestational day, at approximately the same time of
day as mating occurred, the does were again weighed and in some cases
venous blood was collected.

This was accomplished by cutting the super-

ficial vein at the lateral aspect of the ear and allowing the blood to
drip into a collecting tube.

This blood was sent to the clinical bio-

I
t

chemistry laboratory at Loyola University's Foster McGaw
evaluated by the automated SMA-12 test series.

Hosp~tal

and

Following collection of

blood, the does were killed by injecting 30 ml of air into the same
vein which was used to collect blood.

This procedure resulted in a

massive air embolism and the rapid death of the animal.
Immediately following death, the abdominal cavity of the animal
was opened by a rapid mid-ventral incision.

The fetuses were then

obtained by a hysterotomy, removed from the amniotic sac and weighed.
To prevent the fetuses from breathing, and thus becoming neonates,
pressure was applied to the trachea, first by the thumb and then by
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the rapid application of a ligature placed around the neck.
In order to maintain uniformity between experiments, fetuses of
corresponding uterine placement were used for each procedure whenever
possible.

The most lateral fetus of the right uterine horn was re-

moved first, as above, and the thorax opened by a mid-ventral incision.
The entire upper and lower lobes of the right lung were removed, independently chopped into approximately 1 mm cubes and fixed in 2% glutaraldehyde buffered to pH 7.2 with .2M Sorenson's phosphate buffer.

The

left lung was fixed in toto by immersion in 10% buffered formalin.
Simultaneously, the fetuses of the left uterine horn were removed, as
above, and their lungs and livers frozen immediately by immersion in
liquid nitrogen.

In some cases the right lower lobe of the most lat-

eral fetus in the left uterine horn was used for scintillation autoradiography as explained below.
Fetal lung tissue obtained on the 28th gestational day bas
'

studied using all of the procedures described below under thei, heading
"Tissue Processing and Data Procurement" and constitute the bulk of
the project.
In some cases portions of maternal lung were removed and fixed
in 10% buffered formalin for paraffin embedding.

In one case portions

of various maternal organs, including liver, kidney, gastrointestinal
tract, uterus and others, were similarly removed and fixed.
Standard Regimen -- 31 days
In two experiments (Table I) a delay was allmved between the
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maternal administration of pilocarpine and sacrifice of the animal,
in order to determine whether pilocarpine treatment resulted in any
long: term deleterious effects on the fetal lung and its maturation.
The does were injected using the standard regimen, that is with 5 mg/kg
pilocarpine or with saline on the 24th through the 27th gest;ational
day.

Subsequently these does were maintained without additional treat-

ment until the 31st gestational day, at which time the experiments
were terminated.

Fetal lung tissue obtained at 31 days was fixed in

2% glutaraldehyde and analyzed using electron microscopy as well as
electron microscopic stereology (see below).

In addition, fetal and

maternal lung tissue were fixed in formalin for paraffin embedding.
Time-Course Studies
In order to establish a time-course of the effects of maternal
administration of pilocarpine, treatment was begun as with the standard
regimen but the animals were killed before the 28th gestatiorial day.
i

I

Pregnant does received pilocarpine or saline injections, beginning
with the 24th gestational day, and were sacrificed at the 25th, 26th
and 27th gestational day.

Therefore, these does were treated for 1, 2

or 3 days at the time of sacrifice (Table I).

Additional controls

included fetuses of 29 and 30 days gestation obtained from non-injected
does.

Again, fetal lung tissue was analyzed by electron microscopy

and stereology as explained below.
Single Injection Studies
Pilot studies early in the project included experiments dealing
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with the short term effects of maternal administration of pilocarpine
on the fetal lung. At different days of gestation, various strength
doses (10-80 mg/kg) were administered to the pregnant females, which
were then sacrificed at various times post-injection (2-24 hours).
These experiments are sunnnarized as part of Table I.

Fetal :lungs

obtained in these studies were examined by routine light and electron
microscopy.
Injection of Fetuses In Utero
In two cases pilocarpine was injected directly into the fetus,
thus by-passing the maternal route used in the remainder of the
experiments.

In order to accomplish this, pregnant does (one at the

26th day and one at the 27th day) were given general anesthesia and
a laparotomy was performed.

The fetuses of the left uterine horn were

injected intraperitoneally, through the uterine wall and amniotic sac,
with 10 mg pilocarpine in 0.5 m1 of 0.9% saline.

Fetuses of the right

horn were given 0.5 ml of saline alone, in the same manner.

I

the abdo-

I

minal incision of the doe was then sutured, and following the intramuscular injection of antibiotic the does were allowed to recover.

At

24 hours post-injection the doe was killed and lung tissue obtained
from the fetuses as explained above.

This tissue was then analyzed

using electron microscopy.
Tissue Processing and Data Procurement
Glycogen Determination
The lungs and livers of the 28 day fetuses which were frozen by
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immersion in liquid nitrogen were used for the determination of glycogen content.
of

~urat

This was accomplished using a modification of the method

and Serfaty ('76).

The entire lung or liver to be analyzed

was first weighed, and then homogenized with 3 ml of citrate buffer
(pH 4.2) in a Waring blender.

For free glucose determination 0.1 ml

of the homogenate was removed.

The remainder was incubated at 37°C

for two hours with the enzyme amyloglucosidase.

This enzyme splits the

glycogen present in the tissue into free glucose residues.

Following

the incubation period 0.1 ml of the homogenate was removed and, along
with the 0.1 ml removed prior to incubation, a blank and a standard
glucose solution were analyzed for glucose.

Samples were deproteinated

by adding 1.1 ml of water, 0.4 ml of barium hydroxide and 0.4 ml zinc
sulfate.

They were then centrifuged and 0.5 ml of the supernatant was

removed.

To this was added 2 ml of PGO (peroxidase and glucose oxi-

dase) enzyme solution and 0.1 ml of the color reagent 0-dianisidine.
The mixtures were then incubated at 37°C for 30 minutes and

t~e

absorb-

I

ency readings were obtained using a Gilford 250 spectrophotometer.

By

using a standard curve the concentration of glucose in each sample was
ascertained.

Subtracting the free glucose value obtained from. the
\

original homogenate (prior to incubation) from that obtained following
incubation with amyloglucosidase, a value of the amount of glucose due
to glycogen breakdown was obtained.

The amount of glycogen in each

lung or liver was expressed as mg/gm tissue.
Paraffin Embedding
The lungs which were fixed in toto in formalin were processed for
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paraffin embedding using an Autotechnicon Model 2A automated tissue
processor timed as follows:

80% ethanol, .5 hr; 95% ethanol, 3 changes

of l,hr each; 100% ethanol, 3 changes of 1 hr each; toluene, 2 changes
of 1 hr each; liquid Paraplast (Scientific Products), 2 changes of 1 hr
each.

Following this the tissue was placed in a vacuum oven for 1 hr

and then embedded in Paraplast.

Sections were cut at 4-6

~m

on an

American Optical rotary microtome and stained with either Harris hematoxylin and alcoholic eosin or Periodic acid-Schiff with (D-PAS) or
without (PAS) diastase (malt U.S.P.) pretreatment.
Electron Microscopy,
Lung tissue placed in glutaraldehyde was allowed to fix overnight in the original fixative solution.

The following morning the

tissue was washed in Sorenson's phosphate buffer for 4 changes of
15 minutes each and then post-fixed in 1% phosphate buffered osmium
tetroxide for two hours.
follows:

The tissue was then rapidly dehydrdted as
'

one 15 minute change in each of 50%, 70% and 95% ethanol;

two 15 minute changes in 100% ethanol; two 15 minute changes in propylene oxide.

They were then placed in a 1:1 mixture of propylene
I

oxide and Epon 812 mixture for 1 hour, in a 3:1 mixture of the same
compounds overnight and then again overnight in a pure Epon 812 mixture.

The following morning the tissue was embedded in fresh Epon 812

utilizing standard BEEM capsules.

The Epon 812 mixture used through-

out this project was prepared volumetrically as follows:
214 ml; DDSA, 216 ml; NMA, 71 ml; DMP-30, 7.5 ml.
stored at -40°C until used.

Epon 812,

This mixture was

Polymerization was carried out at 40°C
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for one day and then at 60°C for two days.
Using a Sorvall MT-1 ultramicrotome and glass knives, 1

~m

sections were cut from the blocks, mounted on glass slides and stained
with toluidine blue.

These sections were used for orientation and

trimming of the blocks for thin sectioning and, in some cases, for
ligl1t microscopic morphometric analysis as explained below.

Using

the same microtome and a diamond knife, thin sections were cut from
the trimmed blocks at a thickness of 600-800 nm.

These sections were

mounted on 200 or 300 mesh copper grids and stained with 5% uranyl
acetate and Reynold's lead citrate ('63).

Ultrastructural examination

was then carried out using an RCA EMU-3H electron microscope with an
accelerating voltage of 100 KV.
Light Microscopic Morphometric Analysis
The 1

~m

Epon sections were used for the light microscopic

i
'

morphometric analysis of the numeric distribution of mature, pr well
I

differentiated, type II alveolar epithelial cells in the lungs of
fetuses obtained at the 28th gestational day from control and pilocarpine treated groups.

Sections of randomly selected blocks were

photographed at 400X magnification on a Zeiss Photomicroscope II using
Kodak PCF-3 film.

The transparencies thus obtained were used in a

blind study where the slides were viewed randomly in a Kodak rear
screen projector.

The number of cells of any type, as well as the

number of well differentiated type II cells in the unit area of the
2
transparency (.035 mm ) were recorded.

Cells of airways other than
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alveoli (bronchi, bronchioles, etc.) or cells of blood vessels larger
than capillaries were not included in the cell count.

The area oc-

cupied by these omitted cells was determined using a standard grid
pattern and subtracted from the unit area of the slide.

The results

of this study were expressed as type II cells/unit area and"type II
cells/1,000 lung parenchymal cells.
Electron Microscopic Morphometry and Stereology
In 28-day fetuses treated with the standard regimen a morphometric analysis of the lamellar inclusion bodies and multivesicular
bodies within the type II cells was undertaken.

Randomly selected

blocks of upper and lower lobe lung tissue from six fetuses in each
group (all from different litters) were thin sectioned and evaluated
in a blind study.

All alveolar epithelial cells which could be ident-

ified as type II cells were photographed at a standard magnification
of 5,800X.

Identification of type II cells at this gestatiodal age
I

was based on cuboidal shape, presence of microvilli and, most! importantly, the presence of at least one lamellar inclusion body.
process resulted in photographs of at least 120 cells from

This

eac~

of the

upper and lower lobes of the two groups (control and pilocarpine
treated).

In these photographs, enlarged to a final magnification of

20,000X, the number of inclusion bodies and multivesicular bodies in
each cell was recorded.

In addition, the size of each lamellar inclu-

sion body, measured at its maximum diameter, was recorded.
In all cases where electron microscopic stereology was undertaken
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20-25 electron micrographs of each of the upper and lower lobes of
both control and pilocarpine treated fetuses were obtained.

For the

28-d,ay fetuses the electron micrographs were selected at random from
those used for morphometry as explained above.

For the 31-day fetuses

and the time-course study they were obtained in a similar fashion to
those of 28-day fetuses.

However, cells of fetuses with gestational

age less than 28 days were not restricted to being type II cells
specifically.

Due to a distinct lack of recognizable type II cells,

according to the identification criteria used at gestational age 28-31
days, any cuboidal cell lining the alveolar space was photographed and
used for stereologic analysis.

Following stereologic analysis a tally

was made of all cells which contained lamellar inclusion bodies in any
volume density.

The latter cells were considered type II cells and

the percent of all cuboidal cells which these constituted was calculated and recorded.

I
I

Stereologic analysis was performed in order to determiri,e the
volume density of major cell components, and employed the methods of
Weibel ('73).

The cell components which were analyzed in the present

study included glycogen, lamellar inclusion bodies, rough endoplasmic
reticulum, Golgi apparatus and mitochondria.

A transparent acetate

sheet imprinted with a 1/4 inch grid (Xerox Corp. #8R377) was placed
over each photograph in turn and held securely in place.

In this

study the points of intersection of the grid lines were used as the
reference points.

Point "hits" then, were defined as the line inter-

sections which fell over a given cell structure.
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Point "hits" were tallied for each of the structures of interest,
fo~

as well as

all other cytoplasmic components, taken as a group.

Thus, any point not falling over one of the cell structures of interest
was grouped under "other" and added to the point "hits" which did fall
over one of the structures named above.

This was done in order to

obtain a total for all point "hits" falling over anything in the
cytoplasmic portion of the cell.

Point "hits" falling over the nu-

cleus were not included.
Using the equation Point Intercept/Point Total (P./P ) =Point
l..

Density (P )
p

= Profile

Density on a test area (A )
a

=

t

Volume Density

(V) (Glagoleff, '33; Chalkley, '43; Weibel, '63, '72), volume densiv

ties were obtained for each of the structures of interest.
Scintillation Autoradiography
In some cases portions of lung approximately 1 mm

x 5 mm

were removed from the periphery of the right lower lobe of th'e most lat1

'

eral fetus in the left uterine horn for evaluation of cell division
using scintillation autoradiography.

The pieces of lung were rapidly

placed in culture media (Gibco minimum essential media, 20% fetal calf
serum) containing

5~Ci/ml

activity 20 Ci/mmol).

tritiated thymidine (Amersham, specific

These were then maintained at 37°C, using a

standard tissue culture incubator, for two hours.

Following incubation

the tissues were fixed in cold 2% phosphate buffered paraformaldehyde
and were allowed to remain in the fixative overnight.

The following

morning they were washed through three changes of Sorenson's buffer.
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Dehydration was then carried out in a graded methacrylate (Polysciences
JB-4 catalyzed solution A, prepared as per kit instructions) series as
follows:

50% JB-4, two changes of .5 hour each; 70% JB-4, two changes

of .5 hour each; 95% JB-4, two changes of .5 hour each; 100% JB-4, two
changes of 1.5 hour each, this step corresponding to infiltration.

The

tissues were then embedded in a 25:1 mixture of JB-4 catalyzed solution
A to JB-4 solution B, as per kit instructions.

To accomplish poly-

merization a block molding cup was used and covered with paraffin.
Following a two day polymerization period sections were cut at 1-1.5

~m

using a DuPont JB-4 microtome and glass knife, and mounted on glass
slides.

These slides were then coated, using standard techniques

(Rogers, '67) with Kodak NTB-3 nuclear track emulsion.

The emulsion

was diluted 1:2 with distilled water, giving a very thin emulsion layer
of approximately 1

~m

thickness.

The emulsion was then allowed to

dry on a cooled metal plate for one hour and the slides were dipped
I

for 10 seconds in a scintillation cocktail which was previously pre'

pared by adding 10 grams of Packard Permablend I premixed scintillator
to 1,000 m1 of dioxane.

Permablend I consists of 90% PPO (2,5-diphenyl-

oxazole) and 9% dimethyl POPOP
benzene]).

([1,4-bis-2(4-methyl-5-phenylox~zolyl)-

The slides were then allowed to dry, placed in light proof

boxes and allowed to expose for three days at 4°C. The exposure time
was able to be shortened to three days because in scintillation autoradiography the S-particles emitted by the tritium, in addition to
causing direct exposure of emulsion grains, also cause photon release
from the scintillator, which further exposes the emulsion.
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The autoradiographs were then developed for two minutes in Kodak
Dektol developer diluted 1:2 with distilled water and fixed in Kodak
Rapi~

fixer for 5 minutes.

Following a 15 minute running water wash

the slides were rinsed through a graded ethanol series, to remove the
residue of the scintillation mixture, and stained lightly with Toluidine
blue (stock solution diluted 1:10 with water).

The autoradiographs

were then photographed at 400X magnification using a Zeiss Photomicroscope II and Kodak PCF-3 film.

Only the outer 0.2 mm of each tissue

section were photographed since anoxic changes (including nuclear
pyknosis) were frequently observed in the central portions of the
tissue fragments.

The transparencies thus obtained were viewed ran-

domly in a rear screen projector.

The numbers of labelled and unlabel-

led alveolar epithelial cells and interstitial cells in each slide
were recorded so as to obtain labelled cell indices (labelled cells/
1,000 cells) for both types of cells.
Statistical Analyses
All data which required statistical analysis were analyzed using
the Student's t-test.

This was accomplished using a Texas Instruments
\

data terminal linked to Loyola University's main computer via an
Anderson Jacobsen acoustic direct audio coupler.

The program utilized

was catalogued as "SNAP" or Statistical Numerical Analysis Package
and is listed on the "Public" file of Loyola's available programs.

RESULTS
Injection of Fetuses In Utero
Light microscopic examination of paraffin sectioned fetal lung
revealed no discernable differences between that of fetuses injected
with pilocarpine in utero and those injected with saline in a like
manner (figs. 1, 2).

However, fetal lung in both groups appeared

more mature than lung obtained from non-operated control fetus'es of
the same gestational age (fig. 9).

Maturational changes observed in

fetuses injected in utero included a loss of glycogen, thinner septa
and the appearance of some surfactant material in the alveolar spaces
(figs. 1, 2).
Electron microscopic studies corroborated these findings in
that there was also ultrastructural evidence of apparent maturational
I

changes present in the lungs of fetuses injected in utero witp either
I

saline or pilocarpine.

I

The type II epithelium of both groups' con-

tained substantially less glycogen than that of non-operated controls
and there appeared to be a stimulation of surfactant

synthesis~

as

evidenced by the increased number of lamellar inclusion bodies and
prominence of other organelles

c~nstituting

of the type II cells (figs. 3, 4).

the secretory apparatus

Although these changes were pre-

sent in both groups, ultrastructural evidence indicated that the effects were accentuated in the pilocarpine-treated group.

There was

no evidence of changes in the type I alveolar epithelial cells in
53
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either pilocarpine or saline injected group, when compared to those
of non-operated controls.
Single Injection Studies
Following a single injection of pilocarpine the pregnant does
exhibited all the signs expected from the administration of a parasympathomimetic agent.

Salivation, lacrimation and diarrhea began

approximately 15 minutes post-injection and persisted for about three
hours.

In those experiments utilizing higher doses of pilocarpine

(i.e. 20-40 mg/kg) these effects were more pronounced and persisted
for a longer time period.

In all cases the does appeared mildly dis-

tressed and their breathing was somewhat labored.

Light microscopy,

however, revealed no apparent deleterious changes in lung obtained
from any of these does at various time intervals (2-24 hours) after
pilocarpine injection.

Electron microscopic evaluation revealed

changes in the type II pneumocytes of these does which indicated a
stimulation of the exocrine secretory function of these

I

cells~

These

changes, which were particularly apparent at two hours post-injection,
included the presence of dilated rough endoplasmic reticulum and increased lamellar inclusion bodies (compare figs. 5, 6).
Fetal lung from cases which utilized varying, single, doses of
pilocarpine (10-40 mg/kg), varying post-injection sacrifice times
(2-24 hours) and varying gestational ages (28-30 days) was also examined.

Although there was some effect in all cases, the results of

these experiments indicated more marked effects of single pilocarpine
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injections in cases involving higher doses, later gestational ages
and shorter post-injection sacrifice times.

Although light microsco-

pic examination in these cases revealed fetal lung virtually indistinguishable from controls, electron microscopy indicated changes in
type II cells of these pilocarpine-treated fetuses which suggested
an increased secretion of surfactant.

These changes resembled those

observed in adult lung, including increased numbers of lamellar inclusion bodies as well as increased multivesicular bodies and rough
endoplasmic reticulum (compare figs. 7, 8).
Standard Regimen--28 days
Experiments involving 28-day fetuses obtained from mothers
receiving daily injections of pilocarpine on the 24th through the
27th gestational day were performed in order to evaluate the effect
of prolonged pilocarpine stimulation.

These constituted the bulk

of the present study.
Maternal Effects
As in the single injection studies, following each pilocarpine
injection the pregnant does exhibited all the signs of parasympathetic stimulation.

Food intake for both the control and pilocarpine-

treated does was standardized and water intake was comparable between
the two groups, averaging 360 + 55 ml per day in the pilocarpinetreated group and 280

± 43

ml in controls.

These values, while some-

what higher in the pilocarpine-treated group, were not statistically
different.

During the four day injection period the pilocarpine-
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treated does exhibited a mild weight loss (average of 3.8%) compared
to a slight weight gain in control animals during the same period
(ave~age

of 2.4%).

This difference is thought to be due to diarrhea,

since food and water intake was essentially the same in control and
pilocarpine-treated animals.

Furthermore, the results of the SMA-12

tests on the serum of the two groups revealed no significant differences in any of the twelve parameters tested (table II).
By light microscopy the lungs of the does which received pilocarpine exhibited some areas of minor atelectasis, but no other
changes were observed.

Additionally, in one case a survey of many

organs, including uterus, liver, gastrointestinal tract and kidney,
was performed by light microscopy which disclosed no apparent abnormalities in any organ from the pilocarpine-treated doe.
Fetal Effects
Fetuses of control and pilocarpine-treated mothers

(her~after

for convenience referred to as control and pilocarpine-treated
fetuses) were comparable grossly, with an occasional dwarf or dead
fetus being found in each group.

The average weight of pilocarpine-

treated fetuses from eight representative does was 26.95 g
SEM) as compared with 35.42 g (±·1.42) for control fetuses.
values were significantly different ( p <0.001).

(±

1.97

These

Grossly the lungs

of pilocarpine-treated fetuses appeared normal, as did all other
organs.
Light microscopic evaluation of paraffin embedded fetal lungs
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TABLE II
RESULTS OF SMA-12 TEST SERIES ON MATERNAL SERUM
Test
Calcium (mg%)

Control
11.38 + 0.46

Pilocarpine
12.68 +

0.08

3.45 +

0.37

2.82 +

0.19

130.00 +

6.18

124.00 +

1.81

19.43 +

4.05

0.57 +

0.03

0.57 +

0.05

27.43 +

2.00

25.33 +

3.13

Total Phosphorus (gm%)

5.00 +

0.20

Albumin (gm%)

0.68 + 0.02

0.671 +

Total Bilirubin (mg%)

0.23 + 0.04

0.26' + 0.03

Inorganic Phosphates (Mg% P)
Glucose (mg%)
Blood Urea Nitrogen (BUN) (mg%)
Uric Acid (mg%)
Cholesterol (mg%)

Alkaline Phosphatase (mU. /ml)
LDH (mU. /ml)
SGOT (mU. /ml)

27.71 +

4.90

181.85 + 23.00
36.00 +

4.43

16.57 + 0.44

5.15 + 0.08
0.02

~-

'

20.66 +

1. 74

294.00 + 71.7
38.33

+ 13.56
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revealed that the lungs of pilocarpine-treated fetuses gave an overall impression of an advanced maturational stage, when compared to
thos~

of controls.

This impression was based on general configuration

and alveolar septal thickness (compare figs. 9, 10).

Examination of

PAS-stained paraffin sections showed a marked decrease in the amount
of PAS-positive material in the lung cells of pilocarpine-treated
fetuses.

In slides stained with PAS after diastase pre-treatment

(D-PAS) no difference was noted between pilocarpine and control fetal
lungs, indicating that the difference originally noted in PAS staining
was due to glycogen content.

The validity of this observation was

substantiated by the biochemical determination of glycogen content.
The results of this study (table III) indicated a significant decrease
in the glycogen content of the lungs of pilocarpine-treated fetuses,
when compared with controls.

There was, however, no significant dif-

ference in the glycogen content of the fetal livers between the two
groups, which would indicate that the difference observed in 1the lungs
I
I

I

was not due to a generalized depletion of glycogen stores in the pilocarpine-treated group.
Light microscopic examination of toluidine blue-stained 1

~m

thick sections of Epon embedded fetal lung reinforced the impression
of an overall appearance of increased lung maturation in the pilocarpine-treated group, again based on alveolar configuration and
septal thickness.

In addition, since the resolution of individual

cells was possible in these plastic sections, it was observed that the
alveoli of the pilocarpine-treated fetuSes appeared, for the most part,
to be lined by cells which were fairly well differentiated into type I
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TABLE III
GLYCOGEN CONTENT (mg/gm tissue)

Number of
Litters

Number of
Fetuses

LUNG

LIVER

CONTROL

5

17

4.11 + 0.33

16.98 + 2.03

PILOCARPINE

7

25

2.65 + 0.13

14.98 + 1.30

p < .001

n:. s.
i

I
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and type II cells (fig, 11).

In contrast, the alveoli of control

fetal lungs were lined by many apparently immature cuboidal cells, as
well ;as type I and type II cells (fig. 11).
These findings were confirmed by light microscopic morphometric
analysis of the distribution of mature type II cells in these lungs.
This study revealed a significant increase in the number of mature
type II cells in the lungs of pilocarpine-treated fetuses, both .per
2

unit area of section (0.035 mm ) and per 1,000 lung cells of any kind
(fig. 12).

Such an analysis was possible since mature, or well dif-

ferentiated type II cells are readily recognizable in 1

~m

thick sec-

tions by their size, shape, position and, most importantly, the
presence of lamellar inclusion bodies (fig. 11).
Ultrastructural examination confirmed that the alveoli of 28-day
control fetal lungs were lined by numerous immature cuboidal cells, as
I

well as type I and type II cells in various stages of differeptiation
I

and maturation (fig. 13).

Immature cuboidal cells are characterized

by very large accumulations of glycogen and show little indication of
differentiation into either type I or type II cells (fig. 26).

In

addition, the alveolar epithelial cells which had already differentiated into type I or type II cells appeared, in general, at a relatively immature stage of maturation.

The nuclei of type I cells in

these control fetal lungs were often surrounded by relatively abundant
cytoplasm, indicative of an immature state.

~.Jhile

the cytoplasmic

extensions of these cells in some areas formed blood-air barriers,
these extensions were frequently thick and contained, in addition to
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accumulations of glycogen, mitochondria and rough endoplasmic reticulum (fig. 15).

In addition, the nuclei of pulmonary capillary endo-

thelia! cells were often found positioned directly adjacent to developing type I cell cytoplasmic extensions, resulting in very thick,
immature, blood-air barriers.
The majority of the type II cells present in 28-day controls
were characterized by abundant glycogen, a poorly developed secretory
apparatus and relatively few multivesicular bodies and lamellar inclusian bodies (figs. 17, 19).

The

inclusion bodies which were present

in these cells often possessed a homogenous core surrounded by relatively few, or less intensely stained, lamellae (figs. 17, 19).
The alveolar epithelium of pilocarpine-treated fetuses demonstrated striking ultrastructural differences from controls in many
respects.

The cells lining the alveoli of these fetuses were, in the

vast majority, well differentiated into type I or type II ceJ!ls, with
i

immature cuboidal cells being extremely rare (fig. 14).

The 6ost pro-

minent change in these lungs was a striking reduction in the glycogen
content of alveolar epithelial cells, with many of these cells.containing virtually no glycogen.
Type I cells of

pilocarpin~-treated

fetuses appeared, in general,

to be at a more advanced stage of maturation than did those of controls.

The nuclei were surrounded by a thin rim of cytoplasm con-

taining sparse organelles and virtually no glycogen.

The cytoplasm

of these cells was most often attenuated to form mature, very thin,
blood-air barriers (fig. 16).

62
When glycogen was present in the type II epithelial cells of
pilocarpine-treated fetuses, it was usually in relatively small
amo~ts

and often associated with surfactant material (fig. 20).

Additional findings in these cells involved maturational changes indicative of an increased

activity of the secretory apparatus which

produces pulmonary surfactant.

These findings included an increase or

dilatation of the rough endoplasmic reticulum associated with the presence of relatively numerous multivesicular bodies and large, densely
osmiophilic, lamellar inclusion bodies which tended to aggregate toward the apex of the cell.

The majority of these inclusion bodies

possessed many well defined lamellae which, according to Kikkawa's
classification ('68), would represent more mature forms (figs. 18, 20).
Lamellar inclusion bodies in type II cells of pilocarpine-treated
fetuses were also seen in the process of being, apparently, secreted
into the alveolar space (fig. 18) with greater frequency than in controls, where this was rarely observed.

I

Also observed more often in
I

pilocarpine-treated fetuses were membranous whorls and segments of
tubular myelin within the alveolar space (fig. 16).

These are indi-

cative of surfactant lipids and as such are the end-result of the
I
secretion of lamellar bodies from the type II cells, as mentioned
above.

The remainder of the organelles within the type II cells were

much the same in the two groups, with the exception of the Golgi apparatus, which appeared prominent, or multiple, with greater frequency
in the type II cells of pilocarpine-treated fetuses.
The ultrastructural morphometric study dealing with the size and
numerical distribution of lamellar inclusion bodies, as well as the
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number of multivesicular bodies within the type II cells of the two
groups substantiated the above interpretations of the electron microscopic findings.

The results of this study (table IV) indicated that

both the number of lamellar inclusion bodies per type II cell and the
average size of the lamellar inclusion bodies were increased significantly in the pilocarpine-treated group when compared to controls.
In addition, the number of multivesicular bodies present in the

type

II cells of pilocarpine-treated fetuses, expressed as number/ ten
type II cells, was also increased significantly over control values.
Further quantification of the ultrastructural differences observed
between type II cells of the two groups was obtained by stereologic
analysis.

The results of this study, expressed as percentages of

total cytoplasmic volume, are listed in table V. These data indicated
that the cytoplasmic volume density of lamellar inclusion bodies,
rough endoplasmic reticulum and Golgi apparatus were increased signiI

ficantly in the type II cells of pilocarpine-treated fetuses.!

The only
'

exception was the volume density of the Golgi apparatus in the type II
cells of the right lower lobe.

In this case the mean value for pilo-

carpine-treated fetuses was higher than that of controls, but this
elevation was not statistically significant.

In addition to these

increases in cytoplasmic components contituting the secretory apparatus and its product, there was a significant decrease in the volume
density of glycogen in the type II cells of pilocarpine-treated
fetuses.

There was no difference in the values obtained for the

volume densities of mitochondria in the two groups.

TABLE IV

RESULTS OF ELECTRON MICROSCOPIC MORPHOMETRIC ANALYSIS ON TYPE II CELLS OF 28-DAY FETUSES
(STANDARD REGIMEN)
Parameter

Control

Pilocarpine

p

Inclusion Bodies/Type II Cell
Upper Lobe
· Lower Lobe
Size of Inclusion Bodies

3.95
3.19

+ .48
+ .39

5.36
5. 02

+ .37
+ .40

<.05
<.01

(~m)

Upper Lobe
Lower Lobe

.692 ± .024
.674 + .034

• 813 + .017
.836 + .031

<,001
<.005

Multivesicular Bodies/
Ten Type II Cells
Upper Lobe
Lower Lobe

1.93
1.47

-+ . 45
+ .29

3.02
3. 43

+ .43
+ . 78_.

<,05
<.05
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TABLE V
RESULTS OF ULTRASTRUCTURAL STEREOLOGY OF 28-DAY (STANDARD

~EGIMEN)

FETAL TYPE II CELLS
Expressed as Percent Cytoplasmic Volume
Structure

Control

Pilocarpine

p

Lamellar Inclusion Bodies
Upper Lobe
Lower Lobe

7.2 + 0.9
5.6 + 0.6

10.6 + 1.0
12.9 + 1.2

<.025
<.001

27.3+1.7
34.3 + 2.2

13.7 + 1. 7
17.6 + 1.7

<.001
<.001

10.9 + .8
14.3 + 2.7

<.005
<.005

Glycogen
Upper Lobe
Lower Lobe

Rough Endoplasmic Reticulum
Upper Lobe
Lower Lobe

7.8 +
5.9 +

.6
.6

2.0 +
2.6 +

.4
.5

3.5 +
3.1 +

.6
•7

<.05
N.S.

8.0 +
6.4 +

.5
.7

8.5 +
7.8 +

.7
.4

N.S.
N. S.

Golgi Complex
Upper Lobe
Lower Lobe
Mitochondria
Upper Lobe
Lower Lobe
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Electron microscopic stereologic analysis of type II cells from
29, 30 and 31-day control fetuses was undertaken in order to ascertain,
by cqmparison, the

overall maturational change in the type II cells,

in terms of gestational days, of 28-day pilocarpine-treated fetuses.
The volume density of lamellar inclusion bodies in the pilocarpinetreated group was not significantly different from values obtained in
29 or 30-day control fetuses (fig. 25).

The glycogen content of the

type II cells of 28-day pilocarpine-treated fetuses was significantly
higher than that of 29, 30 or 31-day-controls.

Rough endoplasmic

reticulum in these cells was not significantly different from 31-day
controls, while the volume density of Golgi apparatus did not differ
significantly from controls of 30-days gestation (fig. 25).
Scintillation Autoradiography
Using scintillation autoradiography, adequate labelling of cells
which had incorporated the
days of exposure.

3
H-thymidine was obtained after oJly three

Cells were considered labelled if there we~e at

least five emulsion grains over the nuclei.

As shown in figure 21,

the labelling obtained with this method was quite distinct and,well
localized over individual nuclei, while background grain exposure was
minimal.

Moreover, the use of 1

~m

thick plastic sections, instead

of thicker paraffin sections, enabled the identification of interstitial and alveolar epithelial cells, based on position, size and histologic features (fig. 21).
The blind study of the labelled cell index of alveolar epithelium revealed that the number of labelled epithelial cells was
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decreased significantly in the pilocarpine-treated group when compared
to controls (fig. 22).

In addition, the number of labelled intersti-

tial, cells was also significantly lower in the pilocarpine-treated
group than in controls (fig. 22).
Standard Regimen--31 days
Maternal lung tissue obtained at the 31st gestational day from
does which had been treated with the same standard regimen (on days
24-27) as those killed at 28 days was studied by light microscopy.
Examination of paraffin sectioned lung stained with H&E, PAS or D-PAS
revealed no noticable differences from adult controls obtained at the
same gestational age.

Fetal lung was similarly studied and again

showed no differences between control and pilocarpine-treated groups.
'

Fetal lung of both groups appeared mature, with thin septa, many
blood-air barriers and very little, if any, glycogen within alveolar
epithelium or cells of the septa.

In addition, some alveola~ spaces
I

of both groups contained D-PAS positive granular material whi!:h is
indicative of surfactant secretion.
Electron microscopic comparison of 31-day fetal lung demonstraed no observable damage in the lungs of fetuses which had been treated
with pilocarpine on gestational days 24-27.

Lung parenchyma appeared

normal and comparable to controls and there was no evidence of any
damage to type II alveolar epithelial cells (compare figs. 23, 24).
Stereologic analysis revealed that the type II cells of pilocarpinetreated fetuses contained a significantly greater volume density of
lamellar inclusion bodies than those of controls (fig. 25).

Addition-

68
ally, although little remained in any cell of either group at 31 days,
the amount of glycogen present in the type II cells of pilocarpinetreated fetuses remained significantly lower than control values (fig.
25).

The volume densities of rough endoplasmic reticulum and Golgi

complex were comparable to controls, however, the volume of'mitochondria was significantly decreased in the pilocarpine-treated group.
Time-Course Studies
Fetal lung obtained from control and pilocarpine-treated fetuses at gestational ages 25, 26 and 27 days was examined by electron
microscopy and the cuboidal cells lining the alveolar space were analyzed by electron microscopic stereology.
At the 25th gestational day the epithelium lining the control
fetal lungs was quite immature, the cuboidal cells being 50% immature
cuboidal cells (table VI).

These cells contained much glyco9en and

some organelles but showed no signs of differentiation (fig. 26).
I

The

other 50% of the cuboidal cells photographed randomly for stereology
were classified as type II cells since they contained very immature
forms of lamellar inclusion bodies or, occasionally, a single multivesicular body.

Stereologic analysis indicated that the cuboidal

cells, as a group, contained roughly 34% (volume density of cytoplasm)
glycogen and barely 0.3% inclusion bodies (fig. 25).

Conversely, the

cuboidal cells of pilocarpine-treated fetuses contained only 25%
glycogen and 1.3% inclusion bodies, these values being significantly
different from controls (fig. 25).

In addition, these cells also
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TABLE VI

PERCENT TYPE II CELLS OF SAMPLED CUBOIDAL CELLS

Gestational Day

Control

Pilocarpine

25

50%

65%

26

70%

75%

27

78%

100%
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contained greater amounts of mitochondria, rough endoplasmic reticulum
and Golgi complex (fig. 25).

Cells classified as type II cells

comprised 65% of the cuboidal cells which lined the alveoli of these
fetuses (table VI).

These cells were, like those of controls,

relatively immature (fig. 27).
Cuboidal cells present at the 26th gestational day in control
fetal lungs contained slightly less glycogen and more lamellar bodies
and Golgi than had those of 25 days (fig. 25).

However,

the ,overall

appearance of the alveolar lining was still quite immature (fig. 28)
even though 70% of the cells photographed were classified as type II
cells (table VI).

Stereology revealed that cuboidal cells of pile-

carpine-treated fetuses at 26 days had changed little from those of
the

previous day (fig. 25).

Thus, at 26 days, the only structure

which differed significantly from control values was the rough endoplasmic reticulum, which was significantly greater in the piLocarpine!

treated group (fig. 25).

The majority (75%) of the cells

'
lin:~ng
!

the alveolar space in this group were characterized as type II cells
(table VI).
The cuboidal cells lining the alveoli of 27-day controls were
characterized by a large increase in lamellar bodies over the previous
day, with a corresponding decrease in glycogen (fig. 25).

Although

78% (table VI) of the cuboidal cells were classed as type II cells,
the inclusion bodies within these cells were characteristically immature forms (fig. 30).

100% of the cuboidal cells which were ran-

domly photographed in pilocarpine-treated fetuses of 27 days gesta-
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tion were classed as type II cells (table VI).

The volume density

of lamellar inclusion bodies and rough endoplasmic reticulum were signific~ntly

greater than in controls while there was significantly less

glycogen (fig. 25).

The lamellar inclusion bodies within these cells

were, for the most part, well developed with distinct and numerous
lamellae (fig. 31).

DISCUSSION
, The findings of this study indicate that maternal administration
of pilocarpine results in stimulation of pulmonary surfactant synthesis and secretion in the rabbit fetus and, in multiple doses, in
accelerated differentiation of alveolar epithelial cells and maturation of the fetal lung as a whole.

Following pilocarpine administra-

tion on days 24 through 27 of gestation, morphologic correlates of
increased

maturat~on

28th gestational day.

were apparent when fetuses were obtained on the
In addition, time-course studies indicated

that some evidence of maturational changes in the lungs of pilocarpine-treated fetuses were apparent as early as the 25th gestational
day.
Based on electron microscopic examination of fetal rabbit lung,
it was determined that the 28th gestational day was the best ~uited
I

I

for the elucidation of changes occurring in the lungs of pilocarpinetreated fetuses.

Thus, the bulk of this study utilized fetuses of

this gestational age.

On the 28th day of gestation control fetal lungs

were found to be relatively immature, in that the glycogen content of
alveolar epithelial cells was high and cuboidal cells lining the alveoli contained relatively few lamellar inclusion bodies.

These find-

ings are at variance to those of Kikkawa et al. ('68; '71) who observed no glycogen in alveolar epithelial cells on day 28 of gestation and
concluded that the rabbit fetal lung was completely mature at this age.
The reason for this discrepancy between the results of the present
72
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study and those of Kikkawa is not clear, but may in part be related to
differences in buffer or dehydration procedure used in tissue processing for electron microscopy.

During the work involved in this

project, it was observed that phosphate buffered glutaraldehyde and a
rapid dehydration procedure are necessary for optimal preservation of
the glycogen present in fetal rabbit alveolar epithelium.

The common

use of cacodylate buffer or prolonged dehydration results in a leaching of glycogen out of the alveolar epithelial cells and the appearance, by electron microscopy, of vacuoles indicating the location of
previous glycogen deposits.
In the present study pilocarpine was administered by a maternal
route to avoid the possibility of stimulatory or maturational changes
in the fetal lung, brought about simply by the trauma inherent in the
operational procedure necessary to inject drugs to fetuses in utero.
Results of the pilot experiments in which pilocarpine or saline were
I
i

injected in utero at days 26 and 27 indicated that the lungs ',of fetusi

es injected with only saline in this manner showed evidence of an
acceleration of maturation when compared to similar fetuses of nonoperated mothers.

These results confirm those of Robert et al~('75)

who, using biochemical parameters, observed maturational changes in
the surfactant system of fetuses·injected with saline in utero.
reason for this apparent stimulation is unclear;

The

it may, however, be

related to endogenous corticosteroid release or autonomic activation
resulting from the surgical trauma to both the mother and fetus.

An additional reason for administering the pilocarpine maternal-
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ly was that a primary aim of the study was to evaluate the effect of
repeated stimulation of the fetal alveolar epithelium over a period of
several days.

This involved multiple administrations of pilocarpine

and, since daily surgical procedures would be impractical, necessitated employing the maternal route for delivery of the pilocarpine.

It

was assumed that pilocarpine would cross the placental barrier since
it is well documented that the vast majority of compounds with molecular weights less than 600 readily cross this barrier (Mirkin and
Singh, '76) and pilocarpine HCl has a molecular weight of 244.7.
Furthermore, when Corbet et al. ('76) administered pilocarpine directly to fetuses in utero, they observed evidence of pilocarpine stimulation in the doe (salivation, lacrimation etc.) indicating that the
drug had crossed the placenta from the fetus to the mother.

Thus, it

may be assumed that passage in the opposite direction, that is from
the mother to the fetus, is also readily accomplished.

I
I

Based on the study by Goldenberg et al. ('69) using adli,lt rats,
i
I

initially 150 mg/kg pilocarpine was administered subcutaneously to the
rabbits in the present study.

Although this dose worked well in non-

pregnant adult rabbits, when administered to pregnant does it resulted
in immediate convulsions and the rapid death of the animal.

In the

single injection experiments of the present study, doses of pilocarpine ranging from 10-80 mg/kg were employed and the larger of these
doses, at times, also resulted in the death of the pregnant doe.

Sub-

sequent experimentation revealed the dosage of 5 mg/kg to be optimal
insofar as the pregnant females exhibited all the signs of parasympathetic stimulation, but neither the doe nor the fetuses suffered any
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increase in mortality.

In addition, electron microscopic results

from the single injection experiments indicated that this dosage was
capable of stimulating the surfactant system of the fetus while proclueing no apparent deleterious effects.
Results of the SMA-12 test series which was performed on the
serum of the pregnant does showed no significant differences between
pilocarpine and saline groups, indicating that pilocarpine administration had no serious deleterious effects on the health or well_being
of the animals.

This was substantiated by the light microscopic

survey of various organs of a pilocarpine-treated doe which revealed
no abnormalities.

Data obtained in this study did, however, reveal

that the body weight of the pilocarpine-treated fetuses was decreased
somewhat compared to controls.
weight is unclear.

The reason for this reduction in

However, it is apparently not directly related to

malnutrition since the food intake and blood glucose level of the

I

mother, as well as fetal liver glycogen, were not reduced from control
values.

Similar weight losses have been previously described in

cortisol-treated rabbit fetuses (Motoyama et al., '71).

Furthermore,

Kotas et al. ('71) have demonstrated that the maturational stage of
the lung is independent of body size in fetal rabbits; in fact, they
observed that, within a given litter, smaller fetuses often had more
mature lungs than larger littermates.
Light microscopic observations of the lungs of 28-day pilocarpine-treated fetuses were consistent with an acceleration of maturation, as judged by general architecture, septal thickness and, in PAS
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stained sections, glycogen content.

Similar parameters have been em-

ployed by many investigators involved in the study of maturational
changes brought about pharmacologically (Kikkawa et al., '71; Wu et
al., '73).

In the present study, however, in order to substantiate

the reduction in glycogen content observed morphologically, a
ical determination of glycogen content was employed.

bioche~

This method

yielded data which agreed with the morphologic observations while also
indicating that, since fetal liver glycogen was not significantly
reduced in the pilocarpine-treated group, the reduction in glycogen
content of alveolar epithelial cells in these fetuses was due to
increased maturation, not malnutrition.
Data obtained through light microscopic morphometric analysis
demonstrated a significant increase in the number of mature, or well
differentiated, type II cells per unit area as well as an increase
relative to the total number of lung cells.

It is of interest that

I

Kauffman ('77), using similar morphometric techniques, obtained
I

\

results much like those of the present study in an investigation of
maturational changes in the lungs of fetal mice following maternal
administration of dexamethasone, a glucocorticoid.

Based on these

findings Kauffman concluded that the alveolar epithelium in her experimental group underwent accelerated differentiation following dexamethasone administration.

The results of the present study suggest

that pilocarpine administration causes a shift away from immature
cuboidal cells and toward differentiation into mature type II cells,
capable of active synthesis and secretion of surfactant.

77

Electron microscopic examination of the lungs of 28-day pilocarpine-treated fetuses revealed ultrastructural differences from
controls which indicated increased maturation of the alveolar epithelium.

The observed epithelial changes are similar to those described

in glucocorticoid (Kikkawa et al., '71) or thyroxine (Wu et !al., '73)
treated fetuses, as well as in other studies employing pharmacologic
means of increasing the maturation of the fetal lung (for review see
Avery, '75).

In the present study quantification of these changes was

aided by the use of ultrastructural morphometry, which indicated that
the number and size of lamellar inclusion bodies, as well as the
number of multivesicular bodies, were increased significantly in the
pilocarpine-treated group.

In order to eliminate possible bias due

to differences in cell size or lamellar body distribution, as well as
to quantify other cell structures, stereologic morphometry was performed.

The goal of this method was to determine the cytoplasmic

I
volume densities of the various cell components which have been
estaI

blished as playing a role in the synthesis and secretion of pulmonary
surfactant in the fetus.

These structures include glycogen, lamellar

inclusion bodies, mitochondria, rough endoplasmic reticulum and Golgi
apparatus.
Results of this study indicated that, at the 28th gestational
day, the volume density of lamellar inclusion bodies and rough endoplasmic reticulum were increased in the pilocarpine-treated group,
while glycogen was decreased compared to controls.

Therefore, not

only are there greater numbers of mature type II cells in the lungs
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of pilocarpine-treated fetuses, as indicated by light microscopic
morphometric analysis, but these cells contain a greater volume density of structures involved in the production, storage and secretion
of pulmonary surfactant.

Associated with these increases is a

decrease in the glycogen content because it is being used for the
synthesis of surfactant phosphatidylcholine as demonstrated by Gilden
et al. ('77) and others.
Comparison of the stereologic results obtained from pilocarpinetreated fetuses at the 28th gestational day with those obtained from
controls at 29, 30 and 31 days revealed that measured components of
the type II cells in 28-day pilocarpine-treated fetuses did not
correspond uniformly to those of any given gestational age in controls.
One problem in interpreting the results of this study was that the
control alveolar type II cells were functionally mature at 29 days.
Therefore, changes in measured cytoplasmic components occurring at 29,
I

30 and 31 days, although indicating further maturation,

'
woul~
I

not

!

alter the viability of the fetus.
When the stereologic data from all gestational ages are considered together (fig. 25) some trends become evident.

The general

trends observed in control fetal lung cell maturation from immature
cuboidal cells to mature type II cells included a decrease in glycogen with advancing gestational age.

The lamellar inclusion bodies

increased gradually through day 28, exhibited a large increase at day
29 and thereafter gradually decreased.

This decline late in gesta-

tion may be related to qaulitative changes of surfactant synthesis,
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storage and release, as well as increased turn-over of surfactant
components.

Associated with these changes was a sudden increase in

rough endoplasmic reticulum at 31 days.

The amount of Golgi complex

within control cuboidal cells remained relatively constant throughout
the time period studied.
It may be stated that, in general, these changes through time
also occurred in pilocarpine-treated fetuses, but either occurred
earlier or to a greater extent than in controls.

At each day except

the 26th gestational day, the cells of the pilocarpine-treated group
contained a significantly greater volume density of lamellar inclusion
bodies and significantly less glycogen.

The reason for the lack of

significant differences in these values at day 26 is unclear.

However,

it probably relates to the fact that on this day the amount of rough
endoplasmic reticulum within the cells of the pilocarpine-treated
group exhibited its largest increase, reaching a value nearll double
that of controls.
The results of the electron microscopic studies would indicate
that repeated stimulation of the exocrine function of fetal alveolar
epithelium with pilocarpine causes not only an increased secretion
of surfactant in mature cells, as does a single dose (Corbet et al.,
'76), but also an increased differentiation and maturation of type II
cells.

This process is marked by an increase in the secretory appa-

ratus of these cells and by an increased utilization of glycogen
stores for the synthesis, storage and secretion of increased amounts
of surfactant.
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It is appropriate to mention that certain forms of fetal distress may produce changes in the fetal lung similar in some respects
to those observed in the present study.

These changes include an

initial stimulation of secretion and a transitory acceleration of
maturation (Balis et al., '75).

However, in the reaction to stress

or injury, these changes are usually accompanied by septal edema,
which was not observed in the present study.

Additionally, it has

been established that following an injurious episode the type II alveolar epithelium of the adult (Evans et al., '75; Witschi, '76) and
fetal

(Balis~

al., '75) lung undergoes a proliferative response.

The light microscopic morphometric results of the present study indicated an increase in the number of mature type II cells in the lungs
of pilocarpine-treated fetuses.

That this is not a response to an

injurious effect of pilocarpine is confirmed by the results of the
scintillation autoradiographic study.

These results indicated that
l

fewer lung cells in the pilocarpine-treated group were actively
I

synthesizing DNA, in preparation for cell division, when the lung
tissue was removed and placed in culture media containing

3
H-thymidine;

thus, they failed to incorporate the labelled precursor and therefore
did not label the autoradiograph.
In addition to indicating changes following injury, cell proliferation has been demonstrated to be a useful criterion for judging
maturation in the fetal lung.

It has been established that cell

proliferation in the fetal lung decreases suddenly in late gestation
(Sorokin, '61; O'Hare and Townes, '70; Kauffman, '75).

The results

of the present study revealed a reduced proliferation of both alveolar
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epithelial cells and interstitial cells in the lungs of pilocarpinetreated fetuses.

It may be concluded, based on these results as well

as morphologic criteria, that pilocarpine administration resulted in
an acceleration of differentiation and maturation of alveolar epithelial cells, at the expense of proliferation.

These epithelial changes

are paralleled by decreased proliferation of mesenchymal cells, resulting in thinning of septa and maturation of the lung as a whole.
With respect to other factors thought to affect fetal lung
maturation, it has been suggested that maternal malnutrition may have
a stimulatory effect on surfactant secretion and lung maturation
(Naeye et al., '74).

Data obtained in a study related to the present

one (Smith, in press) indicate that the lungs of fetuses obtained at
the 28th gestational day from does which were fasted for 6-7 days do
show signs of increased maturation.

The type II cells of these

fetuses, however, are characterized by many morphologically abnormal

!
lamellar inclusion bodies.

In addition to malnutrition,

incr~ased

synthesis and secretion of surfactant was reported by Kikkawa and
Motoyama ('73) in fetal rabbits treated with AY-9944, an inhibitor of
cholesterol biosynthesis.

This stimulation, however, was accompanied

by retardation of the general maturation of the lung.
Pilocarpine has been reported to be capable of stimulating the
secretion of surfactant by type II cells in adult animals (Goldenberg
et al., '69; Morgan and Morgan, '73).

Corbet et al. ('76) have demon-

strated that direct administration of pilocarpine to fetuses results
in a reduction of surface tension, indicating increased secretion of
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surfactant.

Morphologic evidence obtained in the single injection

experiments of the present study suggests that single, maternally
administered, doses of pilocarpine result in the stimulation of surfactant production and secretion in near-term fetal rabbit type II
alveolar epithelial cells.

The mechanism by which pilocarpine causes

this stimulation is, however, unclear.
Pilocarpine is a parasympathomimetic cholinergic agent which
acts primarily at muscarinic receptors of autonomic effector cells.
However, ganglionic effects are also observed in some cases (Koelle,
'75).

As an example, the actions of pilocarpine on the cardiovascular

system are complex and difficult to interpret.

Following administra-

tion of pilocarpine there is, as one would expect, a drop in blood
pressure.

However, if administration is preceeded by a nicotinic

blocking agent, there is a marked increase in pressure.

Atropine, a

muscarinic blocker, abolishes both effects and the increase in pres-

!
sure can be blocked by a S-adrenergic blocker.

It is thought, that
I
\

this complex situation may occur because of an activation of excitatory muscarinic receptors on sympathetic ganglion cells, as well as
adrenomedullary chromaffin cells, both of which receive sympathetic
preganglionic fibers which employ acetylcholine as a transmitter
substance.
central

In addition, it is known that pilocarpine has various

nervous system effects, ranging from evocation of the corti-

cal arousal system, to autonomic and somatic motor effects suggesting
activation of paraventricular hypothalamic nuclei.

The

~ommon

bond

which links the effects of pilocarpine is the ability of atropine to
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completely block them all, which would indicate that they are all due
to activation of muscarinic binding sites.
Hung et al. ('72) demonstrated axonal endings of an autonomic
nature in close proximity to type II pneumocytes and concluded that
(

these provided a morphologic connection between the autonomic nervous
system and surfactant secretion.

It has been demontrated that surfac-

tant secretion is deleteriously affected by vagotomy (Goldenberg
et al., '67); conversely, stimulation of the vagus results in increased surfactant secretion (Oyarzun and Clements, '77).

Judging by this,

it is logical to conclude that the nerve endings observed by Hung and
co-workers are of vagal origin; thus, the type II pneumocytes would
possess muscarinic receptor sites.
In a pharmacologic study, Corbet et al. ('77) theorized that the
action of pilocarpine on surfactant secretion may be due to sympathetic stimulation.

He suggested that the nerve endings presenJ in the
I

lung alveolar wall are of sympathetic origin and that the typ,1e II cells
possessed S-adrenergic receptors.

However, studies by Beckman et al.

('71) and Bergren and Beckman ('76) suggested that sympathetic. stimulation causes a decrease in surfactant activity.

The very fact that

vagal stimulation causes increased surfactant secretion makes it difficult to accept sympathetic, S-adrenergic, innervation of type II
pneumocytes, as Corbet proposed.

It may be speculated that pilocar-

pine, due to its action at the adrenal medullary or ganglionic receptors, is, in fact, acting through an entirely different mechanism than
that activated through vagal efferent stimulation.

However,
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oxotremorine, a synthetic analog of muscarine which has none of pilocarpine's predilection for these sites, has also been demonstrated to
stimulate alveolar type II cells (Abdeblatif and Hollingsworth, '77).
As may be inferred from this discussion, the question of whether the
effect of pilocarpine is due to parasympathetic or sympathetic activation remains unresolved.

However, it seems highly probable that

its action is related to the existence of an autonomic control mechanism for surfactant secretion.
The findings of the present study indicate that repeated pilocarpine stimulation of the fetal rabbit surfactant system results in
increased maturation of the type II epithelial cells of the alveolus,
and the lung as a whole.

The results have much in common with those

obtained through glucocorticoid administration (Kikkawa et al., '71,
and others) and the protocol of the present study does not absolutely
rule out the possibility of endogenous corticosteroid influence.
I

The

I

I

same, however, may be said of any study, to date, which has a:,ttempted
to pharmacologically enhance fetal lung maturation.

The results of

the single injection experiments of the present study, as well as the
results of Pysher ('77) employing fetal lung in culture which was
thus obviously separated from corticosteroid influence, have demonstrated that fetal lung is responsive to pilocarpine.

Furthermore,

in the present study stereologic analysis revealed maturational
changes 24 hours after a single pilocarpine injection at the 24th
gestational day while most studies using corticosteroids cite results
48-72 hours after multiple injections.
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It is probable that normal lung maturation is controlled through
many inter-acting mechanisms and systems, since it is possible, experimentally, to influence lung maturation through a variety of means.
Although the natural role of the autonomic nervous system in the
developing lung is unknown, the results of the present study indicate
that the maturation of the fetal lung can be influenced through autonomic manipulation.

Respiratory distress syndrome of the newborn has

been linked to immaturity of the surfactant system of the lung.

The

results of this study contribute to the knowledge available concerning
factors influencing or controlling the maturation of the fetal lung
and its surfactant system, knowledge essential to promote development
of rational modes of therapy.

SUHHARY
Pilocarpine HCl, a parasympathomimetic drug, was administered
to pregnant white rabbits at various times late in gestation.

Morpho-

1

logic studies indicated that this resulted in a stimulation of surfactaut synthesis and secretion.

The same drug was then administered in

a daily subcutaneous injection of 5 mg/kg on day 24 through day 27 of
gestation.

Fetuses from these animals and from saline injected

controls were obtained by cesarean section on day 28 of gestation,
term being 31 days in the rabbit.

Histologic examination revealed

thinner alveolar septa, and in sections stained with periodic acidSchiff (PAS), a. decrease in PAS positive material in the lungs of
pilocarpine-treated fetuses when compared with controls.

Morphometric

evaluation indicated a significant increase in the number of mature
type II cells in the alveolar epithelium of pilocarpine-treated
fetuses, both per unit area and per 1,000 lung cells of any J,ind.
I

Scintillation autoradiography using 1

I

~m

thick methacrylate sections

of fetal lung, from both groups, which was incubated with

3
H-thymidine

in vitro, revealed a significant decrease in the labelled cell indices
of alveolar epithelial cells, as well as interstitial cells, in the
lungg of pilocarpine-treated fet4ses.
Electron microscopic studies revealed that the alveoli of the
pilocarpine-treated group were lined by epithelial cells at a more
advanced stage of maturation than those of controls.

Type I cells in

the pilocarpine-treated group were consistently well differentiated,
86
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forming thin blood-air barriers.

Ultrastructural findings in type II

cells of this group included a substantial reduction in glycogen content, well developed or dilated rough endoplasmic reticulum and a
significant increase (as determined by morphometric analysis) in the
number and size of lamellar inclusion bodies, as well as the number
of multivesicular bodies.

Electron microscopic stereology indicated

a significant increase in the cytoplasmic volume density of lamellar
inclusion bodies, rough endoplasmic reticulum and Golgi complex in the
pilocarpine-treated group while indicating a significant decrease in
glycogen content.

This observation of decreased glycogen was substan-

tiated by the biochemical determination of glycogen content in the
fetal lungs.
Stereologic analysis of type II cells from fetuses treated with
piloc~rpine

as above but maintained, after cessation of drug admin-

istration at the 27th day, till the 31st day, showed no deleterious
\

effects of pilocarpine treatment; in fact, this study indicat~ed a

I

sustained stimulation of surfactant sythesis and storage.

Similar

studies of type II cells from fetuses treated with pilocarpine for
1, 2 or 3 days and obtained at day 25, 26 and 27 of gestation respectively, yielded a time-sequence of the effect of pilocarpine which
indicated that maturational changes were evident as early as the 25th
gestational day.
The findings of this study provide evidence that maternal
administration of pilocarpine results in accelerated differentiation
and maturation of fetal type II alveolar epithelial cells from immature

88

cuboidal cells, at the expense of proliferation.

This results in

an increased activity of the type II cells in the synthesis, storage
and secretion of pulmonary surfactant.

These changes are accompanied

by decreased proliferation of mesenchymal cells and increased maturation of type I epithelial cells, leading to thinner alveolar' septa
and blood-air barriers and, therefore, increased maturation of the
lung as a whole.
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PLATE I
Figure 1.

Light micrographs of paraffin embedded lung from
a 28-day fetus injected with saline in utero.
Sections are stained with periodic acid-Schiff
(PAS) and thus dark area represent PAS-positive
material: la; Bronchiolar cells (B) contain dark
staining representing PAS-positive glycogen. Septa
are relatively thin with far less PAS-positive
staining than similar lungs of non-operated controls (compare with figure 9a) X 270. lb; Higher
magnification of same lung. While bronchiolar
cells (B) contain abundant darkly stained! glycogen
many alveolar epithelial cells contain little or
none (arrows). Contrast this with figure\ 9b.
X 1060.
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PLATE II
Figure 2.

Light micrographs of paraffin embedded lung from
a 28-day fetus injected with pilocarpine in utero.
Sections are stained, photographed and enlarged
exactly as those of figures 1, 9 and 10. 2a;
Bronchiolar cells (B) contain PAS-positive staining. This lung is much like those of the controls
illustrated in figure 1, with the exception that
following pilocarpine injection, the lungs contain
even less PAS-positive glycogen. Note surfactant
material (S) in alveolar space. X 270. 2b; Higher
magnification of the same lung. Arrows indicate
alveolar epithelial cells containing little or no
glycogen. X 1060.
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PLATE III
Figure 3.

Electron micrograph of a type II cell from the
lung of a 28-day fetus injected with saline in
utero. Lamellar inclusion bodies (L) are relatively numerous while glycogen (G) is scant.
Compare with figure 17, which shows a similar cell
from a non-operated control. R, rough endoplasmic
reticulum; Go, Golgi complex; A, alveolar space.

X 15,000.
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PLATE IV
Figure 4.

Electron micrograph of a type II cell from a fetus
injected with pilocarpine in ute~o. Note large
lamellar inclusion bodies (L) aggregated at the
apex of the cell with one (arrow) apparently about
to be discharged into the alveolar space (A).
X 15,000.
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P~EV

Figure 5.

Electron micrograph of a typical adult rabbit type
II alveolar epithelial cell. Note the vacuolar
appearance of lamellar inclusion bodies (L) and
inconspicuous rough endoplasmic reticulum (R).
Go, Golgi complex; M, Mitochondria; A, Alveolar
space. X 21,000.
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PLATE VI
Figure 6.

Electrotl micrograph of a type II cell from an
adult rabbit which received a single injection of
pilocarpine (150 mg/kg) two hours prior to sacrifice. Large lamellar inclusion bodies (L) are
located apically and rough endoplasmic reticulum
(R) is dilated. A, Alveolar space. X 31,000
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PLATE VII
Figure 7.

Electron micrograph of a type II cell from the
lung of a 29-day control fetal rabbit obtained
early in the project. Note greater development of
lamellae within the lamellar inclusion bodies (L)
when compared to those of the adult. Glycogen (G),
which is virtually absent in adult type II cells,
is also present within this cell. A, Alveolar
space; M, mitochondria; Go, Golgi complex.
X 16,800.
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PLATE VIII
Figure 8.

Electron micrograph of type II epithelial cells
from a 29-day fetus whose mother had received 40
mg/kg pilocarpine six hours earlier. Rough endoplasmic reticulum (R) is dilated, glycogen is
very scant and lamellar inclusion bodies (L) are
apically located with one in each cell being apparently secreted (arrows) into the alveolar space
(A). X 21,000.
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PLATE IX

Figure 9.

Light micrographs of paraffin embedded lung from
a 28-day control fetus. 9a; Note relative thickness of alveolar septa and heavy PAS staining in
bronchiolar (B), septal and alveolar epithelial
cells. X 270. 9b; Higher magnification of same.
Alveolar epithelial cells (arrows) contain large
amounts of PAS-positive glycogen. X 1060.
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PLATE X

Figure 10.

Light micrographs of paraffin embedded lung from
a pilocarpine-treated 28-day fetus. lOa; Alveolar
septa are, for the most part, thinner than controls while PAS-positive staining is negligible.
X 270. lOb; Higher magnification of same. Alveolar epithelial cells (arrows) contain little
or no PAS-positive glycogen X 1060.
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PLATE XI

Figure 11.

Light micrographs of 1 ~m thick toluidine blue
stained sections of 28-day fetal lungs. lla;
Low power of control. Note thick alveolar septa
and relatively sparse blood-air barriers. X 550.
llb; Higher magnification of same. A mature type
II cell is shown at the arrow. Portions of the
alveolar space are lined by immature cuboidal
cells (c) which contain abundant darkly stained
glycogen. X 2,200. llc; Low power of pilocarpine treated fetal lung. Note· thinner alveolar
septa and better development of blood-a~r barriers. X 550. lld; Higher magnification
of same.
I
Mature type II cells containing intensel~ stained
lamellar inclusion bodies are noted at the arrows.
X 2,200.
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Figure 12.

-

The histogram on the left illustrates the numerical distribution of mature, or well differentiated type II alveolar epithelial cells per unit
area (0.035 mm2) of a 1 ~m thick section of fetal
lung from the upper and lower lobes of each group.
On the right is a similar histogram of the number
of mature type II cells per 1,000 lung parenchymal cells. P, pilocarpine-treated; C, control.
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PLATE XII
Figure 13.

Survey electron micrograph of a 28-day control
fetal lung. Type II cells (II) contain large
amounts of glycogen and few lamellar bodies.
Blood-air barrier (BAB) is very thick and the
epithelial component contains a heavy accumulation
of glycogen. A, alveolar space; RBC, red blood
cell in alveolar capillary lumen; I, interstitial
cell. X 6,000
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PLATE XIII
Figure 14.

Survey electron micrograph illustrating alveolar
epithelial cells of a 28-day pilocarpine-treated
fetus. Type II cells contain little glycogen and
relatively numerous lamellar inclusion bodies.
Blood-air barriers (BAB) are well developed and
thin. E, endothelial cell of capillary; C, capillary lumen; A, alveolar space. X 6,000.
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PLATE XIV

Figure 15.

Type I alveolar epithelial cell from a 28-day
control rabbit fetus. Nucleus (N) is surrounded
by abundant cytoplasm containing much glycogen
(G). Cell extension is thin on the right and
forms blood-air barrier over capillary (C). On
the left side the cell extension is thick, contains mitochondria (M) and rough endoplasmic reticulum (R) and overlies a capillary endothelial
cell (E). A, alveolar space. X 14,000.

Figure 16.

Type I cell of a 28-day pilocarpine-treated fetus.
Nucleus (N) is surrounded by a thin rim of cytoplasm containing virtually no glycogen. I Cell
extensions are attenuated to form blood-air barriers over capillary lumens (C). Note surfactant
material (S) in alveolar space. X 10,000.
\

'
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PLATE XV

I

Figure 17.

Type II cell of a 28-day control rabbit fetus.
The cytoplasm contains abundant glycogen (G) and
few lamellar inclusion bodies (L), usually containing sparse lamellae. A, alveolar space.
X 13,000.

Figure 18.

Type II cell of a 28-day pilocarpine-treated
fetus. Glycogen is virtually absent while lamellar inclusion bodies (L) are numerous and show
well developed, darkly staining lamellae. Notice
lamellar body apparently in the process 1of being
secreted (S) into the alveolar space (A)!,, as well
as a multivesicular body (MV) and well developed
cisternae of rough endoplasmic reticulum' (R).
X 10,500.
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PLATE XVI
Figure 19.

Portion of a 28-day control type II cell. Note
glycogen (G) and indistinct lamellae of inclusion
body (L). M, mitochondrion; N, nucleus.
X 30,000.

Figure 20.

Portion of a type II cell from a pilocarpinetreated fetus. Glycogen (G), when present, is
usually found in association with surfactant material (L). Note transitional form of inclusion
body (T). M, mitochondrian. X 33~000.
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PLATE XVII
Figure 21.

Light micrograph of a 1 ~m thick plastic section
of a control fetal lung illustrating the labelling obtained through scintillation autoradiography. Labelled alveolar epithelial cells (short
arrows) and interstitial cells (long arrows) are
readily identified. X 1,380.
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Figure 22.

Histogram illustrating the results of the 3Hthymidine incorporation study on the alveolar
epithelium and lung interstitium of pilocarpinetreated (P) and control (C) rabbit fetuses. Results are expressed as labelled cells per 1,000
cells and the small lines represent the standard
error of the mean.
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PLATE XVIII
Figure 23.

Electron micrograph of a type II cell from a 31day control fetus. Glycogen (G) is, by now,
scarce and lamellar inclusion bodies (L) well
developed. A, alveolar space. X 10,500.

Figure 24.

Electron micrograph of a type II cell from a 31day fetus which was treated with pilocarpine on
days 24 through 27 of gestation. No evidence
of damage is apparent. A, alveolar space.
X 14,000.
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Figure 25.

Histograms illustrating the results of the electron microscopic stereologic analysis of various
cell components involved in the synthesis and
secretion of surfactant. Results are expressed
as percentages of cytoplasmic volume and the small
lines represent the standard error of the mean.
Numbers at the bottom of each graph represent
gestational age. C, control; P, pilocarpinetreated.
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PLATE XIX

Figure 26.

Electron micrograph of an immature cuboidal cell
lining the alveolus of a 25-day control fetus.
Note lack of lamellar inclusion bodies and abundant glycogen (G). A, alveolar space. X 13,000.

Figure 27.

Electron micrograph of an immature type II cell
from a 25-day pilocarpine-treated fetus. Glycogen (G) is less abundant than in controls, while
the secretory apparatus is more apparent. Note
immature form of inclusion body (IF). Go, Golgi
complex; A, alveolar space. X 14,000. \
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PLATE XX
Figure 28.

Electron micrograph of an immature type II cell
from a 28-day control fetus. Glycogen (G) has
decreased from 25-day levels. Note immature
forms of inclusion bodies (IF). A, alveolar
space. X 13,500

Figure 29.

Electron micrograph of an immature type II cell
from a 26-day pilocarpine-treated fetus. These
cells differed little from similar cells of 25days. G, glycogen; Go, Golgi complex; Ir, immature inclusion body; A, alveolar space. • X 13,500
1

\
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PLATE XXI
Figure 30.

Electron micrograph of a type II cell from a 27day control fetus. Glycogen (G) is fairly abundant. Note intermediate form of lamellar inclusion body (arrow) as well as mature forms (L).
X 13,000.

Figure 31.

Electron micrograph of a type II cell from a 27day pilocarpine-treated fetus. Lamellar inclusion bodies (L) are mature and relatively numerous while glycogen (G) is becoming scant,. Note
dilated rough endoplasmic reticulum (R).I A,
alveolar space. X 11,000.
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